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ABSTRACT 
Fructose-1,6-bisphosphatase (FBPase) catalyzes the reaction of fructose-1,6-bisphosphate to 
fructose-6-phosphate and inorganic phosphate. The investigations described here concern 
the structure and function of FBPase, with special focus on those properties relating to the 
allosteric regulation of catalysis. It is our hypothesis that a loop spanning residues 52 
through 72 plays a crucial role in the mechanism of allosteric regulation. Testing this 
hypothesis, a fluorescent reporter group was incorporated into loop 52-72, confirming the 
existence of three states of the loop dependent on the state of ligation: disordered, 
disengaged, and engaged. Furthermore, restriction of backbone flexibility by replacement of 
two residues located in the hinge of loop 52-72 with proline broadly effects catalysis and the 
mechanism of AMP regulation. The N-terminal region of the enzyme assists in stabilizing 
the loop 52-72 in this region of the protein in the disengaged state. Deletion of the first ten 
residues or specific point mutations dramatically alters the mechanism of allosteric 
regulation. A model describing the relative free energies associated with the three states of 
loop 52-72 was generated to account for the functional properties of wild-type and mutant 
enzymes displaying biphasic inhibition by AMP. To further describe the mechanism of AMP 
inhibition, a method for producing and isolating hybrid enzymes was developed. 
Spontaneous subunit exchange was used to create hybrids between wild-type enzyme and a 
mutant with disrupted AMP-binding sites. The hybrid enzymes having different 
arrangements of two subunits either capable or incapable of binding AMP, reveal a specific 
pathway for AMP binding to the tetramer. Overall, the work presented here is a significant 
advancement in the understanding of the fundamental mechanisms of allosteric regulation of 
FBPase. 
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CHAPTER 1. GENERAL INTRODUCTION 
Thesis Organization 
The alternative manuscript-based format is used in this dissertation. This general 
introduction chapter will provide a brief description of our experimental approach and 
motivation for research, and a review of the literature that has lead to the work described in 
this dissertation. The next five chapters are peer-reviewed published papers, all of which I 
am the first author. 1 was responsible for the design and implementation of the experiments 
found in these manuscripts, with the exception of the cristallographie and/or structural 
modeling in chapters two and three, which were performed by either Dr. Jun-Yong Choe or 
Cristina Iancu, graduate students of Dr. Honzatko. The final chapter will give a brief 
summary of the experiments described in the previous chapters. 
Experimental Approach and Motivation for Research 
The work described here is concerned with how the structural features of porcine 
fructose-1,6-bisphosphatase (FBPase) are responsible for the regulation of catalytic activity. 
In general, our experimental approach begins with an examination of the crystal structure, 
followed by the formulation of a hypothesis that relates a specific structural feature to an 
enzymatic property. To test the hypothesis, site-directed mutagenesis is used to alter the 
chemical nature of chosen residues, followed by the heterogenous expression of the mutant 
enzyme in Escherichia coli. The mutant enzyme is purified to homogeneity and studied 
using a variety of biochemical techniques. The principle technique used is enzyme kinetics, 
a mathematical description of what affects the rate of an enzyme catalyzed reaction and how 
these effectors function at the molecular level (1). In addition to enzyme kinetics, 
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fluorescence is heavily relied on to monitor conformational changes that occur during the 
regulation of catalysis (2). 
The purpose behind our investigation of the structure and function of FBPase is two­
fold. First, we wish to understand the fundamental mechanisms of allosteric regulation (3). 
The basic feature of allostery is the energetic linkage between two regions of a protein, 
usually located many angstroms apart. Allosteric regulation acts as a molecular switch, 
turning on or turning off a particular function of the protein. In general, enzymes that 
catalyze highly exergonic, irreversible reactions, are multi-subunit proteins that are 
allosterically regulated and display cooperativity in the binding of allosteric effectors. In 
addition to enzymes, a variety of other proteins are regulated through allosteric mechanisms, 
e.g. human hemoglobin. Several membrane bound receptors are regulated by small molecule 
ligands, such as ligand gated receptors or gated ion channels (4-5). Muscle contraction 
involves cooperativity and allosteric interactions between the protein components of the thin 
muscle filament (6). Similar to hemoglobin and aspartate transcarbamoylase (ATCase) (7-8), 
FBPase is a model protein for the study of allosteric regulation. FBPase has multiple 
allosteric properties, much is known about its structure, and the biochemical properties of the 
enzyme are well understood (see literature review below). Furthermore, unlike hemoglobin 
and ATCase, FBPase is made up of only a single peptide chain, allowing for a more rigid 
framework in which to build an allosteric model. We feel that the investigation of the 
allosteric regulation of FBPase will make a significant contribution toward the understanding 
of this fundamental biochemical process. 
A second goal of FBPase research is to aid in the effort to develop new therapeutic 
approaches to treat type 2 diabetes. Hyperglycemia is the hallmark of type 2 diabetes and is 
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largely responsible for the chronic complications associated with the disease such as 
retinopathy and nephropathy (9). Several therapies are in development, most important of 
which are aimed at reducing hepatic glucose production (10). In addition to the hormonal 
signaling pathway, several enzymes have been identified as molecular targets for diabetic 
therapy including glycogen phosphorylase, glucose-6-phosphatase, and fructose-1,6-
bisphosphatase (11-13). To regulate the activity of an enzyme, it is essential to understand 
the molecular mechanisms responsible for its activity and inhibition. Several 
pharmaceutical companies are currently attempting to produce specific inhibitors of FBPase 
(13-14). The structure/function investigations we are performing on FBPase can aid in the 
rational design or improvement of novel inhibitors. In fact, our lab has been collaborating 
with industry to structurally and biochemically characterize new allosteric inhibitors of 
FBPase with the goal of increasing their potency. 
Literature Review 
Glucose is the major energy source for all mammalian cells, and is the only source of 
energy for the brain under normal physiological conditions (15). Fructose-1,6-
bisphosphatase catalyzes the reaction: fructose-1,6-bisphosphate to fructose-6-phosphate and 
inorganic phosphate (16-17). This reaction is the rate controlling step of the gluconeogenic 
pathway, an energy requiring process that produces glucose from metabolic precursors such 
as pyruvate, lactate, glycerol, and a subset of amino acids (18). The breakdown and 
production of glucose occurs mainly in the liver and kidneys of mammalian organisms. Due 
to the opposing nature of these two pathways, their uncontrolled flux would result in a futile 
cycle, i.e., the wasteful hydrolysis of ATP. Hence, the glycolytic and gluconeogenic 
pathways are tightly regulated (19). The regulation is implemented through the synthesis and 
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degradation of the unique enzymes in these pathways and by the rise and fall in the 
concentrations of metabolic effectors (18). The former method of control is effective over a 
period of days, whereas the latter occurs on a time scale of minutes. Both methods of control 
are modulated by the hormones glucagon and insulin, which cause opposite changes in the 
metabolic state of the organism (18). When an animal is in a state of starvation, the 
pancreatic p cells produce glucagon, which travels through the blood steam to the liver where 
it binds to plasma membrane receptors (20). The binding event triggers a cellular cascade 
resulting in the activation of adenylate cyclase, leading to an increase in cyclic AMP (cAMP) 
(21). cAMP activates cAMP-dependent protein kinase, which in turn phosphorylates specific 
enzymes related to metabolic regulation. When the organism is in the fed state, pancreatic 
cells secrete insulin, reversing the effect of glucagon by activating the enzyme cAMP 
phosphodiesterase, thus lowering cellular cAMP levels (18). 
cAMP-dependent protein kinase phosphorylates a number of substrate proteins, 
however, only one directly affects the activity of FBPase, the Afunctional enzyme fructose-
6-phosphate-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) (22). Although PFK-
2/FBPase-2 has two opposing activities, a single activity dominates depending on its 
phosphorylation state. During starvation, phosphorylation of PFK-2/FBPase-2 occurs 
through the action of glucagon and results in the net decrease in fructose 2,6-bisphosphate 
(F26P2). In the fed state, the opposite occurs, PFK-2/FBPase-2 is dephosphorylated and the 
activity of the enzyme is shifted to the production of F26Pa from F6P and ATP. F26Pa does 
not participate as an intermediate in a metabolic pathway, but lies at an important juncture 
between the hormonal and metabolic pathways. F26Pz, is an activator of the glycolytic 
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enzyme phosphofructose kinase (PFK-1) and a potent inhibitor of gluconeogenic FBPase 
(23). 
In 1981, F26Pa was discovered as an inhibitor of FBPase independently by the Pilkis 
group and by Van Shaftingen and Hers (24,25). Although it is well established that F26P% is 
a competitive inhibitor of FBPase with respect to FI6P2, the mechanism of inhibition has 
been controversial (26). On the basis of chemical modification studies, several groups 
concluded that F26P; binds to an allosteric site on the enzyme (27-29). These studies 
demonstrated that F26Pa and FI6P2 give differing levels of protection to the enzyme from 
modification and the protection afforded by F26Pg was similar to that given by AMP. 
Alternatively, NMR distance measurements using Mn2+ as a paramagnetic cation and F26Pz, 
F6P, and FI6P2 as a phosphorus probe demonstrated that the distance between the cation and 
the inhibitor, substrate, and products are identical (30). It wasn't until a high-resolution 
crystal structure became available that the controversy was resolved, F26P2 was found at the 
active site of the enzyme (31). 
AMP is a non-competitive inhibitor with respect to substrate and is cooperative in 
binding and inhibition (32-33). Chemical modification studies demonstrate that binding of 
AMP to the enzyme produces a different conformational state than the active conformation 
(34). Generally, AMP inhibition has been analyzed in terms of the allosteric inhibition 
model of Monod, Wyman, and Changeux, which involves a concerted transition between two 
states of the enzyme, a relaxed state (R-state, active) and a tense state (T-state, inhibited) 
(35). 
Initially, the in vivo importance of AMP inhibition was unclear because cellular 
concentrations of AMP remain rather constant due to the reaction of adenylate kinase (35). 
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Following the discovery of inhibition of FBPase by F26P%, which occurred after the 
discovery of AMP inhibition, the importance of AMP inhibition became clear. Van 
Schaftingen and Hers demonstrated that AMP and F26P% are synergistic in their inhibition of 
FBPase (25). This means that in the presence of low concentrations of F26P% (non-inhibitory 
alone), the affinity of AMP increases up to 10-fold (25). NMR experiments demonstrated 
that binding of F26P% makes AMP "stickier" by decreasing the dissociation rate constant of 
AMP by 27-fold (36). Because of synergism, even though the level of AMP is relatively 
constant in vivo, the inhibition of FBPase brought about by AMP is modulated by the rise 
and fall of F26P?. 
It has long been recognized that the FBPase reaction absolutely requires divalent 
metals. In 1943 Gomori described a phosphatase requiring Mg2+ for activity, which had high 
affinity for hexose bisphosphates (37). Early studies demonstrated the inverse relationship 
between AMP affinity and its required divalent metal, Mg2+, Mn2+, or Zn2+ (33, 37,38). This 
inverse relationship was first observed in activity assays and demonstrated in more detail 
using detailed kinetic analysis and employment of steady-state fluorescence using a 
fluorescent AMP analogue, formycin-5'-monophosphate (39). 
Binding studies using divalent cations have had varying results. Many of the early 
metal binding experiments were performed using proteolyzed enzyme, negating the 
conclusions drawn from those studies. Using non-proteolyzed enzyme, two different binding 
sites have been observed using Mg2+ and Mn2+, and three have been demonstrated using Zn2+ 
ions. Cooperative interactions between these binding sites have been difficult to 
demonstrate, some groups have observed cooperativity in metal binding and others have seen 
no interaction between Mg2+ binding sites (40-43). Although metal binding experiments 
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have been inconsistent, it is well established that the activation effect due to increasing 
concentrations of Mg2+ cation has on velocity is sigmoidal (33). 
William Lipscomb and colleagues reported the first crystal structure of FBPase in 
1989 (44). The structure confirmed the tetrameric nature of the enzyme, exhibiting D2 
symmetry and containing two different subunit interfaces. The four subunits were named CI 
through C4 counting in a clock-wise direction. The two subunit interfaces are between 
subunits C1-C2 and C1-C4. 
Two quaternary conformations were observed when the crystals were soaked or co-
crystallized with different effectors. The presence of AMP produces the conformation 
known as the T-state, whereas absence of AMP with or without active site ligands produces 
the R-state (45). The R- and T-state structures differ by a 17° rotation of the top dimer (Cl-
C2) relative to the bottom dimer (C3-C4). Each subunit has two domains, the AMP domain 
(residues 1-200) and the FBP domain (residues 201-335). The binding site for the allosteric 
effector, AMP, is located approximately 28 A away from the nearest active site. 
Much of the crystallographic work has focused on the mechanism of allosteric 
inhibition by AMP. Based upon the initial R- and T-state crystal structures, Zhang et al. 
described two possible pathways of allosteric communication between subunits (46). 
Importantly, within the FBP domain, all interactions between subunits CI and C2 are 
conserved, eliminating the possibility of communication between those subunits in that 
region of the FBP domain. Essentially all conformational changes during the R- to T-state 
transition occur in the AMP domain, and more specifically in helices HI and H2. Helices HI 
and H2 make contacts across both the C1-C4 and C1-C2 interfaces, complicating the 
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assignment of a specific subunit interface to signal propagation between AMP sites based 
solely upon ciystallographic data. 
Several site-directed mutants have been made in an attempt to determine which 
interface participates in allosteric site-to-site communication, or if both are involved in signal 
transmission (47-52). The most convincing mutation affecting AMP cooperativity is 
Arg22 Met (47). Arg22 of subunit Cl hydrogen bonds with backbone carbonyl 27 of 
subunit C4 in the T-state of wild-type FBPase. This inter-subunit hydrogen bond is absent, 
however, in the R-state. Removal of the positively charged side-chain completely eliminates 
AMP cooperativity with no other effect on the kinetic parameters. The mutation of this 
residue strongly implicates the C1-C4 interface in AMP binding site communication. 
Following the mutation of Arg22, several other residues located in the C1-C4 interface were 
examined with similar results (48-51). 
Due to the small number of contacts between subunits in the C1-C2 interface, fewer 
residues have been investigated using site-directed mutagenesis. Asp 187 is located in the 
C1-C2 interface, making a hydrogen bond with Lys50 of the neighboring subunit. Mutation 
of this Asp 187 to either alanine or phenylalanine has no effect on AMP cooperativity or any 
other kinetic parameter (50, Iancu et al., unpublished results). Mutation of Lys50 to 
methionine also has no affect on the kinetic properties of the mutant enzyme. However, 
mutation of Lys50 to alanine or glutamine has broad effects on the functional properties of 
the mutant (52). These mutants lack AMP cooperativity, retain high AMP affinity, and also 
alter the kinetic mechanism of AMP inhibition with respect to Mg2+ from competitive to 
noncompetitive and from noncompetitive to uncompetitive with respect to substrate. Based 
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upon these results, the authors assigned the C1-C2 interface as an important participant in the 
AMP communication pathway. 
Dr. Jun-Yong Choe of the Honzatko group made an extremely important contribution 
to the understanding of FBPase structure and function in 1998 by solving a new R-state 
structure co-crystallized with F6P, Pi, and ZnCh (53). The structure revealed a loop 
spanning residues 52 through 72, which was disordered in all previous crystal structures. 
Three zinc cations were present in the active site of the enzyme and the loop 52-72 was 
engaged over the active site of its own subunit with several side chains providing functional 
groups to the active site. Asn64 makes a hydrogen bond with Glu98, a residue that when 
mutated decreases the activity of the enzyme 10,000-fold (54). Asp68 coordinates the zinc 
cation at site 3 and makes a hydrogen bond with Arg276, a residue also important for activity 
(55). Lys71 participates in a hydrogen bond network with Serl23, Gly58, Lys72, and Lys74. 
Mutation of Lys74 reduces activity of the enzyme by over 50,000-fold (56). 
Based upon the new R-state crystal structure and the T-state structure of Lipscomb, 
Choe et al. proposed a new model for the allosteric regulation of catalysis (53). In the R-
state, the loop 52-72 cycles between the disordered and engaged conformations. The 
engaged conformation is required for catalysis, and the disordered conformation allows 
substrate to bind and products to leave the active site. Binding of AMP orders the area 
around the AMP site and causes a 0.9° translation along the axis of helix H2, which in turn 
disengages loop 52-72 from the active site. The removal of loop 52-72 from the active site 
lowers the affinity of the catalytic metal ion, thus effectively shutting down catalysis. 
The literature reviewed above represents the state of the field prior to the initiation of 
my work. The proposed model of allosteric regulation, formulated on the basis of structural 
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data, is substantiated by the functional studies described in chapters two and three. This 
work led to the identification of an additional element involved in the allosteric mechanism 
of inhibition, the N-terminal region. The importance of the inter-subunit interaction between 
loop 52-72 and the N-terminal region is demonstrated in chapter four. Finally, to further 
describe the mechanism of allosteric regulation, hybrid enzymes were used to investigate 
communication between subunits. The development of the method for creating hybrid 
enzymes and the application of hybrid enzymes are described in chapters five and six, 
respectively. The hybrid enzymes revealed two pathways of allosteric inhibition, one where 
two AMP molecules bind to the top and bottom halves of the tetramer in a cooperative 
fashion, and another where two AMP molecules binds non-cooperatively to the same half of 
the tetramer. 
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CHAPTER 2. TRYPTOPHAN FLUORESCENCE REVEALS THE 
CONFORMATIONAL STATE OF A DYNAMIC LOOP IN RECOMBINANT 
PORCINE FRUCTOSE-l,6-BISPHOSPHATASEf 
A paper published in Biochemistry 
Scott W. Nelson, Cristina V. Iancu, Jun-Yong Choe, Richard B. Honzatko, 
and Herbert J. Fromm 
Abstract 
Wild-type porcine fructose-1,6-bisphosphatase (FBPase) has no tryptophan. Hence, the 
mutation of Tyr57 to tryptophan places a unique fluorescent probe in the structural element 
(Loop 52—72) putatively responsible for allosteric regulation of catalysis. On the basis of 
steady-state kinetics, circular dichroism spectroscopy, and X-ray crystallography, the 
mutation has little effect on the functional and structural properties of the enzyme. 
Fluorescence intensity from the Trp57 mutant is maximal in the presence of divalent cations, 
fructose 6-phosphate and orthophosphate, which together stabilize an R-state conformation in 
which Loop 52—72 is engaged with the active site. Fluorescence emission decreases 
monotonically with increasing levels of AMP, an allosteric inhibitor, which promotes the T-
state, disengaged-loop conformation. The titration of various metal/product complexes of the 
Trp57 mutant with fructose 2,6-bisphosphate (F26Pa) causes similar decreases in 
fluorescence, suggesting that F26Pz and AMP individually induce similar conformational 
states in FBPase. Fluorescence spectra, however, are sensitive to the type of divalent cation 
(Zn2+, Mn2+, or Mg2+), and suggest conformations in addition to the R-state, loop-engaged 
and T-state, loop-disengaged forms of FBPase. The present work demonstrates the utility of 
fluorescence spectroscopy in probing the conformational dynamics of FBPase. 
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Introduction 
Fructose-1,6-bisphosphatase (D-fructose-1,6-bisphosphate 1-phosphohydrolase, EC 
3.1.3.11; FBPase1) catalyzes the hydrolysis of fructose 1,6-bisphosphate (FI6P2) to fructose 
6-phosphate (F6P) and inorganic phosphate (Pi) (1,2). FBPase, along with fructoses-
phosphate 1-kinase, define a futile cycle in the gluconeogenic/glycolytic pathways. Hence, 
FBPase activity is regulated tightly, being inhibited by F26P% and AMP (3-5). The kinetic 
mechanism of AMP inhibition is nonlinear and noncompetitive with respect to FI6P2 and 
nonlinear and competitive with respect to Mg2+ (6,7). FBPase requires divalent cations 
(Mg2+, Mn2+, or Zn2+), and rates of reaction vary sigmoidally with metal ion concentration 
(Hill coefficient of 2) (8-10). AMP binds to allosteric sites, which are 28 À from the nearest 
active site (11). F26Pz shows competitive inhibition kinetics with respect to FI6P2, and 
binds to the active site as a substrate analog. AMP and F26Pa inhibit FBPase synergistically 
(3-5). Indeed, the kofr for AMP decreases in the presence of F26P: (12). 
FBPase is a homotetramer [subunit Mr of 37,000 (13)], which exists in at least two 
conformational states called R and T (14,15). AMP, with or without F26Pa, stabilizes the 
inactive T-state (16-18). The active R-state is favored by substrates or products in 
combination with metal cations (14,19). Directed mutations implicate Loop 52—72 in the 
allosteric regulation of FBPase (20,21). Product complexes with FBPase in the presence of 
Mg2+ and Zn2+ reveal an ordered loop, closely associated with the active site. Product 
complexes with AMP, on the other hand, reveal a disordered loop, and all but one metal 
cation displaced from the active site (22). A mechanism for allosteric regulation of catalysis 
in FBPase, proposed by Choe et al. (19), involves two conformational states of Loop 52—72 
(called engaged and disengaged). AMP, and presumably F26Pz, stabilize a disengaged loop, 
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whereas metal cations stabilize an engaged loop. 
Although cristallographie studies provide rich detail, they are difficult to perform 
over a broad range of experimental conditions. Furthermore, the process of crystallization 
selects typically only one family of closely related conformera from what might be a diverse 
population of conformera in solution. Hence, in order to complement X-ray diffraction 
studies, and provide information regarding FBPase conformera over a variety of experimental 
conditions, we have introduced a spectroscopic probe in Loop 52—72. As porcine FBPase 
has no tryptophan, a directed mutation can easily introduce a unique fluorophore. Tyr57 of 
Loop 52—72 is an attractive target for tryptophan substitution. Tyr57 has a large side chain, 
which exists in different environments in the engaged and disengaged conformation of Loop 
52—72. Reported here are the kinetic and structural properties of the Trp57 mutant of 
FBPase, and its conformational response, as measured by steady-state fluorescence 
spectroscopy, to a variety of metal cations and physiologically relevant ligands 
Materials and Methods 
Materials—FI6P2, F26P], NADP+, AMP, ampicillin and IPTG were purchased from Sigma. 
DNA-modifying and restriction enzymes, T4 polynucleotide kinase and ligase came from 
Promega. Glucose-6-phophate dehydrogenase and phosphoglucose isomerase came from 
Roche. Tryptone, yeast extract and agar were from Difco. Other chemicals were of reagent 
grade or the equivalent. Escherichia coli strains BMH 71-18 mutS and XL 1-Blue came from 
Clontech and Stragene, respectively. FBPase-deficient strain DF 657 was from the Genetic 
Stock Center at Yale University. 
Mutagenesis of FBPase— The mutation was introduced by changing specific bases in double 
stranded plasmid using the Transformer™ site-Directed mutagenesis kit (23). The primer for 
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the Tyr57—>Trp mutation was 5 '-CGCACCTCTGGGGAATGG-3 ' (codon for tryptophan 
underlined in bold typeface). The selection primer, 5'-
CAGCCTCGCCTCGAGAACGCCA-3 ' (digestion site underlined in bold typeface), 
changed an original Nrul to a Xhol site on the plasmid. Unanticipated mutations were ruled 
out by sequencing the entire gene, after which the mutant plasmid was used in the 
transformation of E. coli DE 657 (DE3) cells. The Iowa State University sequencing facility 
provided DNA sequences, using the fluorescent dye-dideoxy terminator method. 
Expression and Purification of Wild-type and Mutant FBPases— Expression and purification 
of FBPase was performed as previously described (24) with minor alterations. After cell 
breakage, the enzyme was concentrated by adding enough ammonium sulfate to produce a 
70% solution. The precipitate was then taken up in 20 mM Tris, pH 7.5, and desalted on a 
G-100 Sephadex column using the re-suspension buffer. Fractions with FBPase activity 
were loaded onto a Cibacron-Blue column and eluted with a NaCl gradient (0.5—1 M). 
FBPase appeared at approximately 0.8 M NaCl. The eluent was then dialyzed against 20 
mM Tris-HCl, pH 8.3, and loaded onto a DEAE Sephadex column and eluted with a NaCl 
gradient (0—0.3 M). FBPase appeared at a salt concentration of 0.15 M. Protein purity was 
determined by SDS-PAGE (12% gel) (25). Protein concentration was determined by the 
method of Bradford (26), using bovine serum albumin as a standard. 
Kinetic Experiments— All assays employed the coupling of phosphoglucose isomerase and 
glucose-6-phosphate dehydrogenase (1). Specific activity, kal, and pH 7.5/9.5 activity ratios 
were determined by directly monitoring the reduction of NADP+ to NADPH at 340 nm. All 
other kinetic experiments monitored the fluorescence emission from NADPH at 470 nm, 
using an excitation wavelength of 340 nm (7). Initial rate data were analyzed using programs 
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written either in MINITAB (25) or by ENZFITTER (26). 
Circular Dichroism (CD) Spectroscopy—Spectra were recorded from 200—260 nm in steps 
of 1.3 nm on a Jasco J710 spectrometer in a 1 mm cell at room temperature using a protein 
concentration of approximately 0.25 mg/mL. Spectra were recorded in 20 mM Tris, pH 7.5, 
and with 20 mM Tris, 5 mM Mg2+, 5 mM KP„ and 5 mM F6P, with and without AMP (400 
pM) or F26P% (240 |iM). Each spectrum was blank-corrected and smoothed using the 
software provided with the instrument. 
Crystallization of the Trp57 Mutant—Crystals of both T- and R-state product complexes 
grew from hanging drops of 4 \iL total volume. T-state crystals grew from equal volumes of 
a protein solution [Trp57 mutant (10 mg/mL), Hepes, (100 mM, pH 7), ZnCh (2 mM), F6P 
(5 mM), KP, (10 mM, pH 7), and AMP (5 mM)] and a precipitant solution [Hepes (lOOmM, 
pH 7) and polyethylene glycol 3350 (17% w/v)]. R-state crystals grew from equal volumes 
of a protein solution, as above only omitting the AMP, and a precipitant solution [Hepes (100 
mM, pH 7) and polyethylene glycol 3350 (6% w/v)]. Wells contained 500 pL of the 
precipitant solution. Crystals grew in approximately 2 days at 37° C. 
Data Collection— Data were collected from one T-state crystal (dimensions 0.3 x 0.2 x 0.3 
mm) and one R-state crystal (dimensions 0.3 x 0.3 x 0.4 mm) at Iowa State University on a 
rotating anode/Siemens X-1000 area detector at 120 K, using Cu-Ka radiation passed through 
a graphite monochromator. Data were reduced by XENGEN (29). 
Model Refinement— Initial phases were calculated from the Zn2+/product complex of wild-
type FBPase (18) for the R-state structure and from the AMP/Zn27product complex (22) for 
the T-state structure. Refinement employed XPLOR (30) as described previously (19). 
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Constants of force and geometry for the protein came from Engh and Huber (31). In early 
rounds of refinement, models were heated to 2000 K and then cooled to 300 K in steps of 25 
K. In later rounds of refinement the systems were heated to 1000 K and cooled in steps of 10 
K. After the slow cooling protocol was complete, the models were exposed to 120 steps of 
conjugated gradient minimization, followed by 20 steps of individual B-parameter 
refinement. Individual B-parameters were subject to the following restraints: nearest 
neighbor, main chain atoms, 1.5Â2; next-to-nearest neighbor, side chain atoms, 2.0 À2; 
nearest neighbor, side chain atoms, 2.0 Â2; and next-to-nearest neighbor, side chain atoms, 
2.5 Â2. Water molecules were fit to difference electron density of 2.5a or better and were 
added until no significant decrease was evident in R^. Comparison of the mutant and wild-
type structures employed programs from the ccp4 suite of programs (32). 
Steady-State Fluorescence Measurements— Fluorescence data were collected using a SLM 
8100C fluorimeter from Spectronic Instruments. In order to avoid exciting tyrosyl side 
chains, an excitation wavelength of295 nm was used. Emission spectra were recorded in 
steps of 2 nm from 310 to 400 nm, using a slit width of 2 mm. Enzyme concentrations were 
from 0.2 to 0.5 |aM. Each spectrum was an average of 5 to 7 scans. Ligands were added to a 
solution of tryptophan (100 gM), to ascertain whether they alone influenced fluorescence 
emission from tryptophan. Blanks were subtracted from all spectra, and corrections for 
protein dilutions were made. Conditions under which specific spectra were recorded are 
provided in the text, tables and figure legends. 
AMP titration data were analyzed by non-linear least squares fits, using the following 
equation: 
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AF _(AFJF,)«Z' 
^  * , + r  
(Eq. 1) 
where AF is the change in fluorescence caused upon addition of ligand L, F0 is the 
fluorescence in the absence of ligand, K& is the dissociation constant, and n is the Hill 
coefficient. 
Results 
Kinetic Properties of wild-type FBPase and the Tyr57-+Trp Mutant— Wild-type and mutant 
proteins behave identically in chromatographic separations and are at least 95% pure by 
SDS-PAGE. The ratio of catalytic rates at pH 7.5 to 9.5 indicates an intact (non-proteolyzed) 
FBPase. The mutation of Tyr57 to tryptophan does not affect kinetic parameters 
significantly (Table I). The K\ values for inhibition by AMP and F26PZ increase 5- and 4-
fold, respectively, relative to wild-type FBPase. Other mutations of Loop 52—72 cause 
increases in K\ values for AMP and F26Pa (20,21), and along with the Trp57 mutant here, 
may simply reflect the well-documented binding synergism of these ligands (6-8). Data from 
initial rate assays indicate no change in the mechanisms of inhibition by AMP and F26P2. 
Secondary structure analysis— The CD spectra of wild-type and Trp57 FBPases are 
identical from 200 to 260 nm (data not shown). CD spectra for the Trp57 mutant changes in 
response to AMP, as noted in previous work on the wild-type enzyme (15). The Trp57 
mutant also responds to the addition ofF26P%, yielding a CD spectrum identical to that 
observed in the presence of AMP. 
Crystal structures of R-state and T-state Trp57-FBPase— Crystals of the Trp57 mutant 
grown in the presence of Zn2+ and products (F6P and Pi) belong to the space group 1222 
(a=51.57,6=82.47, c=165.57 A), and are isomorphous to the R-state, Zn2+/product complex 
of the wild-type enzyme (19). Similarly, crystals of the Trp57 mutant grown in the presence 
of Zn2+, products, and AMP belong to the space group P2,2|2 (a=59.82, 6=165.48, c=79.29 
Â), being isomorphous to the T-state, Zn2+/product/AMP complex of the wild-type enzyme 
(22). Statistics for data collection and refinement for both crystal forms are in Table II. The 
stereochemistry of the models is generally very good as determined by PROCHECK (33). 
The method of Luzzati (34) indicates an uncertainty in coordinates of approximately 0.3 À 
for both structures. 
Residues 22—27 and 142—143 are in weak electron density and have high thermal 
parameters in the R-state complex. The root-mean-square deviation between C° atoms of the 
Trp57 and wild-type FBPases is 0.28 Â for the entire model and 0.2 Â for Loop 52—72. 
Deviations up to 1.6 Â are in regions of weak electron density, noted above. Distinct and 
strong electron density covers Trp57 and residues in its vicinity (Fig. 1). The indole moiety 
of Trp57 occupies the same pocket as the side-chain of Tyr57 of the wild-type enzyme, and 
is in contact with Ala51, Gly52, Leu126, Leu129 and Asp127 of its own subunit and Val196, Met172 
and Met185 from the adjacent subunit (C1-C2 interface). 
Residues 55—62,142—143 and 267—269 are in weak electron density in the T-state 
complex. Indeed, although residues 63—70 are part of the model, they are associated with 
electron density no higher than the noise level of the map. The root-mean-square deviation 
between Ca atoms of the mutant and wild-type structures is 0.39 À over the entire model and 
0.28 À for residues 52—62 of the loop. Deviations greater the 1 Â appear amongst residues 
63—70, 142—143 and 267—269, because of absent or weak electron density. A modest 
level of electron density, however, covers Trp57 (Fig. 2). In fact, the indole group of Trp57 
occupies the same space as the side-chain of Tyr57 in the wild-type T-state complex (22). 
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The indole moiety of Trp57 is in contact with lie53 and lie56 of its own subunit and Val196, 
Ile10 and Ile194 of an adjacent subunit (C1-C2 interface). Trp57 is more exposed to solvent in 
the T-state (8.1 Â2 accessible surface area to a 1.4 À probe sphere), than in the R-state (6.4 
À2 accessible surface area). Higher B parameters in the T-state relative to the R-state, 
suggest greater conformational mobility for Trp57 in the T-state structure. Indeed, position 
57 is in proximity to residues 63—70, which are disordered completely and without electron 
density. The only difference between wild-type and Trp57 FBPases in the T-state concerns 
the binding of Zn2+. In the wild-type structure there is only one metal ion bound (at site 1), 
whereas in the mutant structure, in addition to the metal at site 1, electron density appears at 
site 2, which is consistent with a Zn2+ cation at less than 40% occupancy or a water molecule. 
Steady-State Fluorescence from the Trp57 mutant— Ligands, alone or in combination, do not 
influence the fluorescence emission from a 100 pM tryptophan solution. In addition, the 
metal site proximal to Trp57 in the R- and T-states is 15 and 23 A away, respectively. These 
distances exclude most quenching mechanisms except resonance energy transfer and electron 
transfer. Resonance energy transfer is not possible, simply because Mg2+, Zn2+, and Mn2+ do 
not absorb in the range of fluorescence emission from tryptophan. Electron transfer between 
the excited-state tryptophan and Mn2+ is possible, but is not reflected in the experimental 
data. The emission spectra of product complexes with Mn2+ and Zn2+ are equal in intensity, 
whereas that of Mg2+ is relatively low (see below). Electron transfer between Mn2+ and 
Trp57, however, should reduce the emission intensity from the Mn2+/product complex 
relative to that from Mg2+ or Zn2+ complexes. Similarly, resonance energy transfer between 
bound AMP and Trp57 is not possible, because AMP does not absorb in the range of 
fluorescence emission of tryptophan. Recorded differences in fluorescence emission, then, 
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must come from ligand-induced conformational changes, which alter the environment of 
Trp57. 
All changes in fluorescence emission reported here are relative to the emission from 
the Trp57 mutant in the absence of ligands and divalent metal cations. The emission 
spectrum from the Trp57 mutant in the presence of Zn2+ (50 pM), F6P (5 mM), P, (5 mM), 
and saturating AMP (400 nM) has a Xma, of 340 nm and a fluorescence intensity 
approximately equal to that of the ligand-free enzyme (Fig. 3, Table III). In the absence of 
AMP, the fluorescence emission increases by 69% and shifts to 350 nm. The emission 
spectrum from the Trp57 mutant in the presence of F26P? (240 pM), with or without Zn2+, 
F6P and P., is 15% higher, than that from the Zn2+/product/AMP complex, with a Xma, of 342 
nm. The addition ofF26P2 to the Zn2+/product/AMP complex, however, causes no 
detectable change in fluorescence emission (data not shown). 
The emission spectra in the presence of F6P (5 mM), Pj (5 mM), and AMP (400 pM) 
with Mg2+ (5 mM) or Mn2+ (0.5 mM) are identical to that of the Zn2+/product/AMP complex 
(Fig. 3, Table III). In the absence of AMP and in the presence of products, however, Mg2+ 
causes a much smaller increase in fluorescence emission (23%) and a smaller shift in Xma* to 
346 nm, than does either Zn2+ or Mn2+. The addition of K+ (as KC1) at levels (150 mM) 
sufficient to saturate the monovalent cation site, caused no change in fluorescence emission. 
The emission spectrum in the presence of products, F26P2 and Mg2+, however, is nearly 
identical to that of the corresponding complex with Zn2+. Fluorescence emission from the 
Trp57 mutant in the presence of products, F26P2 and Mn2+, is 46% above that of the 
metal/product/AMP complexes, compared to 15% and 11% increases, respectively, when 
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Zn2+ and Mg2+ are used. 
The change in fluorescence from the Zn2+/product complex in response to the titration 
of AMP establishes a K4 for AMP of 16 pM and a Hill coefficient of 2.1 (Fig. 4). These 
values are very close to the I50-AMP (22 pM) and Hill coefficient (2.0) determined by 
kinetics at saturating Mg2+ concentrations (5 mM). 
Discussion 
The mutation of Tyr57 to tryptophan results in only minor changes in the functional 
and structural properties of FBPase. Crystal structures of the Zn2+/product complex of the 
Trp57 mutant in the presence and absence of AMP are virtually identical to those of the wild-
type enzyme under the same conditions of crystallization. Using Mg2+ as the cation 
activator, many of the functional properties of FBPase (activity ratio at pH 7.5 to 9.5, t, Km 
for FI6P2, potassium activation, Hill coefficients for Mg2+ and AMP) are indistinguishable 
from those of the wild-type enzyme. The 4- and 5-fold increases in K\ values for F26P2 and 
AMP, respectively, do indicate a mutation-dependent change in functional properties; 
however, the elevated K\ values probably result from the enhanced stability of the R-state 
relative to the T-state of the mutant. Elevated K, values for both AMP and F26P2 are 
consistent with the model of Choe et al. (19), which requires AMP-bound and F26P2-bound 
states of FBPase to have disengaged loops. Any mutation, which stabilizes an engaged Loop 
52—72, should increase the K\ values of AMP and F26P2. Under extremes in ligand 
concentration (AMP absent and AMP saturating) and the presence of Zn2+/products, the 
Trp57 mutant adopts R- and T-state conformations of the wild-type enzyme. Furthermore, 
initial velocity assays indicate no change in the kinetic mechanisms of inhibition by AMP 
(competitive with respect to Mg2+, noncompetitive with respect to F26P2) and F26P2 
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(competitive with respect to FI6P2). Evidently, tryptophan at position 57 is a non-perturbing 
spectroscopic probe of enzyme function and conformation. 
Common quenchers of tryptophan fluorescence are water, the peptide bond, and 
specific amino acid side chains (35). The indole group of Trp57 in the T-state, however, is 
neither close to a side chain particularly effective as a quencher nor does its exposure to 
solvent differ significantly from that in the R-state (8.1 versus 6.4 À2). FBPase, however, is 
not a static structure. Thermal parameters are an approximate measure of conformational 
dynamics, and on the basis of such parameters, the indole of Trp57 undergoes greater 
conformational movement in the T-state than it does in the R-state. We may observe electron 
density only for the most solvent inaccessible conformer for Trp57 in the T-state. Other 
conformera would convolute the electron density of Trp57 with that of the solvent, resulting 
in a uniform carpet of electron density, indistinguishable from noise. The wavelength of 
maximum fluorescence emission for tryptophan (Xma*) in water is 352 nm and decreases in 
more hydrophobic environments (36). The observed Xmax for Trp57 in the T-state is 
approximately 340 nm, which is consistent with a mixture of solvent-exposed and 
hydrophobic environments for the indole group. 
Trp57 in the R-state occupies a pocket lined primarily with hydrophobic side chains. 
The thermal parameters for the indole moiety in the R-state reflect a fully occupied 
conformational state, with moderate conformational movement. The Xma* for an indole under 
such circumstances should be blue-shifted relative to tryptophan in solution, but Xma* occurs 
at approximately 350 nm. This anomalous behavior of the indole group in the R-state may 
arise from its specific electrostatic environment, which may be dominated by the negative 
charge of Asp 127 (Figs 1&5). The difference dipole vector, determined from the dipole 
moments of the ground and excited ('La) states of indole lies in the plane of the fused ring 
and is directed approximately as in Fig. 5. The electrostatic field caused by Asp 127 will 
decrease the energy separation between the ground and excited states. That decrease is 
consistent with the 10 nm red-shift in the R-state spectrum relative to the T-state. 
The environment of Trp57 in the R-state may influence fluorescence emission by 
other mechanisms as well. Although the imino group of the indole ring does not make a 
hydrogen bond in the crystal structure, backbone carbonyl 126 and the side chain of Asp 127 
need move by no more than 1Â to hydrogen bond with the indole group. Hydrogen bonding 
with the indole would contribute to the observed red-shift, noted above. Additionally, 
several surrounding side chains are effective quenchers of fluorescence (35). Asp 127, 
His253, Cysl83 and Tyr258 are 3.4,6.8, 7.1 and 7.5 Â, respectively, from the indole moiety 
in the R-state. In the absence of one or several of these side chains, the fluorescence 
emission from Trp57 could increase significantly. 
A two-state system (disengaged loop, T-state and engaged loop, R-state) can not 
account for the variation in fluorescence spectra observed in the present study. Firstly, the 
Trp57 mutant, in the absence of metal activators and other ligands, has a disengaged loop, as 
evidenced by its low fluorescence emission. In fact, the fluorescence spectrum in the 
absence of all ligands is nearly indistinguishable from spectra of metal/product/AMP 
complexes (Fig. 3). On the basis of CD spectroscopy, however, the Trp57 mutant, in the 
absence of ligands, is in the R-state. Evidently, the fluorescence spectrum of the Trp57 
mutant is not sensitive to the quaternary conformation of FBPase (T- or R-state), as is CD 
spectroscopy, but is instead sensitive to the conformational state of Loop 52—72 (engaged or 
disengaged). Work of Lipscomb and colleagues has revealed R-state, disengaged loop 
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conformera of wild-type FBPase under a number of crystallization conditions (37-39). 
Hence, an R-state, disengaged loop conformer for FBPase is probably a well-populated state 
for the enzyme in solution. 
Variations in fluorescence emission levels of metal/product complexes could reflect 
differences in the equilibrium populations of R-state conformera (engaged versus disengaged 
loop). If so, then Mg2+ would be the least effective of the divalent cations in stabilizing the 
R-state, engaged conformation of FBPase. Indeed, of the divalent cation activators, Mg2+ 
binds to FBPase with much lower affinity than either Mn2+ or Zn2+, and its fluorescence 
emission is significantly less than that of Mn2+ or Zn2+. 
Although attractive for its simplicity, the above explanation for the low fluorescence 
emission from the Mg27product complex is difficult to reconcile with the absence of a K+-
induced increase in fluorescence emission. K+ putatively binds to or near metal site 3, which 
is unoccupied by Mg2+ at a concentration of 5 mM (22). Directed mutations of loop residues, 
which weaken Mg2+ association, also abolish Reactivation (21). Hence, if the low 
fluorescence emission observed from the Mg2+/product complex is due to an equilibrium 
mixture of engaged and disengaged conformera, then the addition of K+ should stabilize the 
engaged loop and thereby enhance fluorescence emission. Such is not the case. Evidently, if 
K+ does bind to metal site 3, it does not influence the time-averaged environment of Trp57. 
The low fluorescence emission from the Mg2+/product complex then, may reflect a different 
conformational state for FBPase (see below). 
On the basis of difference spectroscopy, AMP and F26P% stabilize the same 
conformation of FBPase (40), presumably a T-state, disengaged loop conformation. 
Fluorescence emission spectra from the Trp57 mutant in the presence of saturating F26P% or 
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saturating AMP, however, are not identical. The time-averaged environment of Trp57 is 
probably less solvent accessible in metal/F26P2 complexes, than in metal/AMP complexes. 
Conceivably, metal/F26P2 complexes may be an equilibrium mixture of loop engaged and 
disengaged conformers. If so, then Mn2+ must stabilize more of the metal/F26P2 complex in 
the engaged-loop conformation, than either Zn2+ or Mg2+. Indeed, F26P2 is almost 50-fold 
less effective as an inhibitor of FBPase when assayed with Mn2+ than with either Mg2+ or 
Zn2+ (41). Alternatively, the conformation of metal/F26P2 complexes of the Trp57 mutant 
may represent distinct conformational states of Loop 52—72, rather than an equilibrium 
mixture of engaged and disengaged loops. Available crystal structures of F26P2 complexes 
of FBPase may not be faithful representations of metal/F26P2 complexes, because of the 
degradation of F26P2 to F6P on the one hand (42,43) and the inclusion AMP on the other 
(17,44). As the emission spectra of metal/product/F26P2/AMP and metal/product/AMP 
complexes are identical, AMP evidently stabilizes the same T-state, disengaged loop 
conformation to the exclusion of all other conformers. 
Fluorescence spectra of the Trp57 mutant are clearly consistent with a dynamic loop, 
sensitive to cation activators and specific ligands. The crystallographic structures (R-state, 
engaged loop; R-state, disengaged loop; T-state, disengaged loop), however, may represent 
only some of the well-populated conformational states of FBPase in solution. Cation-
dependent differences in fluorescence emission from the Trp57 mutant are real and are in 
harmony with reports of differing kinetic mechanisms and anomeric specificity with Mg2+ 
and Mn2+ (1,45-47). As a consequence of the symmetry inherent in crystal structures, 
FBPase has been represented in solution as a tetramer, which retains three intersecting axes 
of symmetry. Reports are in the literature, however, regarding half-of-sites reactivity and 
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pairwise association of AMP (48,49), which necessarily requires the loss of at least one 
symmetry axis of the tetramer. These asymmetric conformers of FBPase may account for the 
variety of conformational states inferred by fluorescence spectroscopy. 
Abbreviations 
FBPase, fructose-1,6-bisphosphatase; F26Pa, fructose 2,6-bisphosphate; FI6P2, fructose 1,6-
bisphosphate; F6P, fructose-6-phosphate; PI, inorganic phosphate; AMP, adenosine 
monophosphate; SDS-PAGE, sodium dodecylsulfate polyacrylamide gel electrophoresis; 
CD, circular dichroism. 
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Table 1. Kinetic parameters for wild-type and Tyr57™>Trp FBPases. 
Activity ratio K^ Ka-Mg2+ Hill-coef Kj-F26P2 I50-AMPa K^ 
pH 7.5/9.5 sec'1 FI6P2 mM2 Mg2+ |iM activation11 
IViid-fype T.3 22.W).1 1J5±0.1 0.67±0.04 1.9±0.1 ^264±0.005 T61±0.05 16.8±0.3 
Trp57 3.3 24.0±0.07 3.39±0.1 0.53±0.06 1.9±0.1 0.84±0.05 8.5±0.4 16.6±0.4 
"Hill coefficient of AMP inhibition is 2.0, as determined from a plot of Mg2+ vs. AMP at a concentration of 20 jaM F16P2. 
bPercent increase in initial velocity in the presence of Mg2+ (5 times Ka) and F16P2 (5 times Km), caused by the addition of KCI 
(150 mM). 
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Table 2. Statistics of data collection and refinement for Trp57 complexes. 
Global conformation R-state T-state 
Ligands bound F6P, P„ Zn2+ F6P, P„ Zn2+, AMP 
Resolution (À) 2.5 2.5 
No. of measurements 38291 79656 
No. of unique reflections 11308 25328 
Completeness of data (%): 
Data set 88 90 
Last shell (2.7—2.5 A) 74 83 
Rsym3 5.00 6.86 
No. of reflections in refinement^ 9914 23834 
No. of atoms 2646 5153 
No. of solvent sites 111 175 
R-factorc 0.178 0.192 
Rfree" 0.259 0.272 
Mean B (A2) 22 32 
Root-mean-square deviations: 
Bond lengths (A) 0.009 0.008 
Bond angles (deg) 1.56 1.23 
Dihedral angles (deg) 24.7 24.8 
Improper dihedral angles (deg) 1.34 1.23 
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"Rsym = SySi l/y - <Ij>\fLiLjIij, where z runs over multiple observations of the same intensity 
and j runs over crystallographically unique intensities. 
Table II. Footnotes continued. 
6A11 data in the resolution range of 5-2.5 Â. 
^-factor = lUFobsl - |Fcaic||/Z|Fok|, where |Fobs|>0. 
^-factor based upon 10% of the data randomly culled and not used in the refinement. 
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Table 3. Fluorescence emission from ligated complexes of Trp57 FBPase. 
Divalent cation 5 mM F6P & KP; 5 mM F6P & KPj; 5 mM F6P & KP;; 
400 nM AMP 240 |iM F26Pa 
Xjttaxj nm Xmax» nm Fa Xma*» nm Fa Xmax» nm 
None 1.00 340 1.00 340 1.00 340 
Zn2+ (50 |iM) 1.69 350 0.96 340 1.15 342 
Mgz+ (5 mM) 1.23 346 0.96 342 1.11 340 
Mn2+ (0.5 mM) 1.59 350 1.00 340 1.46 348 
'Relative fluorescence emission at Xma, from the Trp57 mutant without divalent cations in the 
presence of F6P (5 mM) and KP; (5 mM). 
Figure 1. Structure of the Trp57 mutant in the R-state. Displayed is a stereoview of 
electron density from a 2F0bS-Fcaic map associated with Trp57 at a contour level of 1er 
(top) and an illustration of two subunits (labeled C3 and C4) of FBPase (bottom). 
Helices HI, H2, and H3 are represented as cylinders in both subunits, whereas Loop 
52—72 (engaged conformer, bold line), Trp57, F6P, and Pj (ball-and-stick models) 
are presented only for subunit C4. The bottom image is draw with MOLSCRIPT 
(50). 
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Figure 2. Structure of the Trp57 mutant in the T-state. Displayed is a stereo view of 
electron density from a 2F„bs-Fcaic map associated with Trp57 at a contour level of Ict 
{top) and an illustration of two subunits (labeled C3 and C4) of FBPase (bottom). 
Helices HI, H2, and H3 are represented as cylinders in both subunits, whereas Loop 
52—72 (disengaged conformer, bold line), Trp57, F6P, Pi, and AMP (ball-and-stick 
models) are presented only for subunit C4. The bottom image is draw with 
MOLSCRIPT (50). 
I le 10# illelO# / ni/ 
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Figure 3. Fluorescence spectra of the Trp57 mutant under different conditions of 
ligation. A. Enzyme under R-state conditions of ligation (5 mM F6P and 5 mM KP,) 
in the presence of 50 pM Zn2+ (•), 0.5 mM Mn2+ ( -), 5 mM Mg2+ (•••), and no 
metal (—). B. Enzyme under T-state conditions of ligation (5 mM F6P, 5 mM KPj, 
and 0.4 mM AMP) in the presence of 50 ^M Zn2+ (—), 0.5 mM Mn2+ ( ), 5 mM 
Mg2+ (•"), and no metal (—). C. Enzyme in the presence of F26P2 (240 ^M) and 
products (5 mM F6P and 5 mM KPJ in the presence of 50 ^M Zn2+ f ), 0.5 mM 
Mn2+ ( - ), 5 mM Mg2+ (•••), and no metal (—). 
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Figure 4. AMP titration of the Trp57 mutant as monitored by fluorescence emission. 
Enzyme is in 5 mM F6P, 5 mM Pi, and 50 pM Zn2+. AMP is added up to a final 
concentration of 0.2 mM. 
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Figure 5. Schematic of the electrostatic perturbation due to Aspl27 on the fluorescence 
emission energy from Trp57. The difference dipole moment Ajj. is the dipole moment of 
ground state indole subtracted from the dipole moment of the *La excited state. Its 
orientation here is based on information provided by Callis (51). The change in energy 
between ground and excited states due to a point negative charge positioned between the 
oxygen atoms of the side chain of Asp 127 is -Ap*E. Given the geometrical relationship of 
Asp 127 to Trp57, the electrostatic perturbation decreases the separation in ground state and 
'La energy levels, causing a red-shift in the fluorescence emission. 
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CHAPTER 3. MUTATIONS IN THE HINGE OF A DYNAMIC LOOP BROADLY 
INFLUENCEFUNCTIONAL PROPERTIES OF FRUCTOSE-1,6-
BISPHOSPHAT ASE 
A paper published in The Journal of Biological Chemistry 
Scott W. Nelson, Jun-Yong Choe, Richard B. Honzatko, and Herbert J. Fromm 
Abstract: 
Loop 52—72 of porcine fructose-1,6-bisphosphatase may play a central role in the 
mechanism of catalysis and allosteric inhibition by AMP. The loop pivots between different 
conformational states about a hinge located at residues 50—51. The insertion of proline 
separately at positions 50 and 51 reduces by up to 3-fold, with no effect on the Km for 
fructose 1,6-bisphosphate (FI6P2). The Ka for Mg2+ in the Lys50-»Pro mutant increases 
approximately 15-fold, whereas that for the Ala5l-»Pro mutant is unchanged. Although these 
mutants retain wild-type binding affinity for AMP and the fluorescent AMP analog, TNP-
AMP, the K\ for AMP increases 8000- and 280-fold in the position 50 and 51 mutants, 
respectively. In fact, the mutation Lys50-»Pro changes the mechanism of AMP-inhibition 
with respect to Mg2+ from competitive to noncompetitive and abolishes K+ activation. The 
K\ for fructose 2,6-bisphosphate (F26P:) increases approximately 20- and 30-fold in the 
Lys50-»Pro and Ala5l-»Pro mutants, respectively. Fluorescence from a tryptophan introduced 
by the mutation ofTyr57, suggests an altered conformational state for Loop 52—72 due to the 
proline at position 50. Evidently the Pro50 mutant binds AMP with high affinity at the 
allosteric site, but the mechanism of allosteric regulation of catalysis has been disabled. 
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Introduction 
Fructose-1,6-bisphosphatase (D-fructose-1,6-bisphophate 1-phosphohydrase, EC 
3.13.11; 
FBPase1) catalyzes the hydrolysis of fructose 1,6-bisphosphate (FI6P2) to fructose 6-
phosphate (F6P) and inorganic phosphate (P,; for a review see 1—3). FBPase is a tetramer of 
identical subunits (Mr = 37,000). Each subunit has binding sites for FI6P2, F26Pz, and metal 
ions, which taken together define the active site, and a distinct AMP binding site (4—6). The 
two binding loci within the same subunit are 28 À apart, lying for the most part in separate 
folding domains (called the AMP and FI6P2 domains). The four subunits of the tetramer 
occupy the comers of a rectangle, labeled clockwise CI through C4, starting with the upper 
right-hand corner (7). FBPase exists in at least two conformational states, called R and T, 
which differ by a 17° rotation of the C1-C2 subunit pair with respect to the C3-C4 subunit 
pair about one of three intersecting twofold axes of the tetramer (7,8). 
Loop 52—72 could play an important role in the allosteric mechanism of AMP 
inhibition, existing itself in at least two conformational states (9,10). In the absence of AMP, 
the loop interacts with the active site (engaged loop conformation), positioning the side chain 
of an essential catalytic residue Asp74 (9,11). The binding of AMP to its allosteric pocket 
putatively displaces the loop from the active site, and stabilizes the disengaged loop 
conformation (9,10). Subunits with disengaged loops evidently have reduced affinity for 
essential metal ions, and as a consequence, may be impaired with respect to catalysis. 
Mutations of conserved residues in Loop 52—72 have significant effects on catalysis and 
allosteric inhibition of catalysis by AMP (11). 
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The metabolic flux through FBPase is sensitive to prevailing levels of AMP and 
F26Pz. AMP inhibits FBPase allosterically with a Hill coefficient of 2 (12,13), whereas 
F26Pz inhibits FBPase by direct ligation of the active site with a Hill coefficient of unity (1— 
3). Inhibition of FBPase by AMP is nonlinear and noncompetitive with respect to FI6P2, but 
nonlinear and competitive with respect to Mg2+ (6,14). In contrast, inhibition of FBPase by 
F26P2 is linear and competitive with respect to FI6P2 and noncompetitive with respect to 
Mg2+. Due to the equilibrium reaction catalyzed by adenylate kinase, concentrations of AMP 
in vivo are nearly constant under normal physiological conditions, whereas the concentration 
of F26P2 varies in response to extracellular regulators such as glucagon and epinephrine. 
Hence, F26P2 is the probable dynamic regulator of FBPase in vivo, but AMP still plays a 
significant role. F26P2 lowers the apparent inhibition constant for AMP at least 10-fold (15) 
by decreasing the kofrof AMP (16). Levels of AMP association with the allosteric sites of 
FBPase, then, will necessarily change in response to F26P2 levels, even if the concentration 
of AMP in vivo is constant. AMP/F26P2 synergism may arise from the ability of each ligand 
to stabilize a common thermodynamic state of FBPase (disengaged Loop 52—72) through 
different mechanisms (9). 
In order for Loop 52—72 to move between its various states, significant 
conformational change must occur in hinge elements at residues 50—51 and 71—72. The 
combined mutation of lysines 71 and 72 to methionine dramatically increases the K\ for 
AMP, presumably due to the stabilization of the R-state over the T-state conformer of 
FBPase (11). If the loop-mediated mechanism of AMP inhibition is valid, mutations at the 
second hinge element must qualitatively cause a similar increase in the K, of AMP. Yet, 
mutations of Lys50 to methionine (17), glutamine, and alanine (18), cause virtually no change 
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in the K, of AMP. What is clear from crystal structures, however, is a large difference in 
main chain angles (<J>,(p) at position 50 in the R- and T-states of FBPase (7,9,10). Here we 
explore the consequence of mutations Lys50-»Pro and Ala51-»Pro, which directly influence 
the backbone conformation of residues 50 and 51. The mutations have little effect on the 
binding affinity of a fluorescent analogue of AMP, but increase the kinetic K, value for that 
analogue by orders of magnitude. The kinetic Km value for FI6P2 is unchanged by the 
mutations, but the Ka for Mg2+ rises 35-fold in the case of the Pro50 mutant, and is 40-fold 
less active under standard conditions of assay. The data suggest Loop 52—72 is an essential 
element in the allosteric mechanism of FBPase. 
Materials and Methods 
Materials—FI6P2, F26P2, NADP+, AMP, ampicillin and IPTG were purchased from Sigma. 
DNA-modifying and restriction enzymes, T4 polynucleotide kinase and ligase were from 
Promega. Glucose-6-phophate dehydrogenase and phosphoglucose isomerase came from 
Roche. Tryptone, yeast extract and agar were from Difco. Other chemicals were of reagent 
grade or equivalent. Escherichia coli strains BMH 71-18 mutS and XL 1-Blue came from 
Clontech and Stragene, respectively. FBPase-deficient strain DF 657 came from the Genetic 
Stock Center at Yale University. 
Mutagenesis of Wild-type FBPase— Mutations were accomplished by specific base changes 
in double-stranded plasmid using the Transformer™ site-Directed Mutagenesis kit 
(Clontech). The mutagenic primers for the Lys50-»Pro, Ala51-"Pro, and Tyr57-»Trp mutants 
were 
5 ' -GTCCGCCCGGCGGGC ATC-3 '. 5 '-CCGCAAGCCGGGCATCGC-3 and 5'-
CGCACCTCTGGGGAATTG3'. respectively (codon for mutation underlined in bold 
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typeface). The selection primer, 5'-CAGCCTCGCCTCGAGAACGCCA-3' (digestion site 
underlined in bold typeface), changed an original Nrul site on the plasmid into a Xhol site. 
The mutation and integrity of the gene was confirmed by sequencing the entire gene. The 
Iowa State University sequencing facility provided DNA sequences, using the fluorescent 
dye-dideoxy terminator method. 
Expression and Purification of Wild-type and FBPase Mutants— Protein expression and 
purification were performed as described previously (11), but with minor alterations. After 
cell breakage, FBPase was enriched and concentrated by 70% ammonium sulfate 
fractionation. The precipitate was taken up in 20 mM Tris, pH 7.5, and desalted on a G-100 
Sephadex column, using 20 mM Tris, pH 7.5. The active fractions were loaded directly onto 
a Cibacron-Blue column and eluted with a NaCl gradient from 0.5 to 1 M. FBPase eluted at 
approximately 800 mM NaCl. The eluent was dialyzed against 20 mM Tris-HCl, pH 8.3, 
loaded onto a DEAE-Sephadex column and then developed with a gradient 0 to 300 mM in 
NaCl. FBPase eluted at a salt concentration of 150 mM and its purity confirmed by SOS-
PAGE (19). Protein concentration was determined using the Bradford assay (20) with bovine 
serum albumin as a standard. 
Circular Dichroism Spectroscopy— CD studies on wild-type and FBPase mutants were done 
at room temperature on a Jasco J710 CD spectrometer in a 1 cm cell, using a protein 
concentration of 0.35 mg/mL. Spectra were collected from 200 to 260 nm in increments of 
1.3 nm. Each spectrum was blank corrected and smoothed using the software package 
provided with the instrument. 
Kinetic Experiments— Assays for the determination of specific activity, kcat, and activity 
ratios at pH 7.5 and 9.5 employed the coupling enzymes, phosphoglucose isomerase and 
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glucose-6-phosphate dehydrogenase (1). The reduction of NADP+ to NADPH was 
monitored directly at 340 nm. All other assays employed the same coupling enzymes, but 
monitored NADPH evolution by its fluorescence emission at 470 nm (excitation wavelength 
of 340 nm). Initial rate data were analyzed using programs written either in the MINITAB 
language, using an a value of 2.0 (14) or by ENZFITTER (21). The kinetic data were fit to a 
variety of models. Only models and parameters for the best fits are reported below. 
Steady-Slate Fluorescence Measurements— Fluorescence data were collected using a SLM 
8100C fluorimeter from Spectronic Instruments. The single tryptophan in the Trp57 mutant, 
was excited selectively, using radiation of wavelength 295 nm. Fluorescence emission 
spectra were recorded in steps of 1 nm from 310 to 400 nm, using a slit width of 2 mm for 
both excitation and emission. Each spectrum was an average of 5 scans. Fluorescence from 
TNP-AMP employed excitation and emission wavelengths of400 and 535 nm, respectively. 
Conditions under which specific spectra were recorded are provided in the text, tables and 
figure legends. Each point is the average of 15, 1-second acquisitions. Enzyme 
concentrations ranged from 0.3 to 0.5 |iM. All spectra were corrected for dilution and inner 
filter effects (absorbance of light by AMP and TNP-AMP) using the following formula (22): 
Fc =(F- B)(Vi/Vo)10<OD"+OD">/2 (Eq. 1) 
where Fc is the corrected fluorescence, F is the fluorescence intensity experimentally 
measured, B is the background, V\ is the volume of the sample for a specific titration point, 
V0 is the initial volume of the sample, ODex is the optical density measured at the wavelength 
of excitation (295 nm for AMP and 410 nm for TNP-AMP), and ODem is the optical density 
measured at the wavelength of emission (535 nm for TNP-AMP). 
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As a control, ligands by themselves caused no change in fluorescence emission from 
a solution of tryptophan (100 |iM). 
TNP-AMP titration data were analyzed by non-linear least squares fits, using the 
following equation: 
AF (AFim/F0)*r 
K d + L * 
(Eq.2) 
where AF is the change in fluorescence caused by the addition of ligand L, F0 is the 
fluorescence in the absence of ligand, AFma% is the theoretical maximum change in 
fluorescence at saturating ligand concentration, Kj is the dissociation constant, and n is the 
Hill coefficient. 
Structural Modeling of FBPase Mutants— The starting model for the engaged conformation 
of Loop 52—72 is the crystal structure of the Zn2+-product complex of FBPase (PDB 
accession code ICNQ), in which the tetramer assumes the R-state conformation (9). The 
starting model for the disengaged conformation of Loop 52—72 is a Zn2+-product-AMP 
complex of FBPase, in which the tetramer has the T-state conformation (10). The latter 
structure is similar to other T-state structures of FBPase (7,23), differing primarily in the 
ligands present at the active site. Proline residues were placed individually at positions 50 
and 51, using the software XTALVIEW and a Silicon Graphics workstation. The initial 
models were passed through two protocols: (i) 100 cycles of conjugate gradient 
minimization, (ii) 100 cycles of conjugate gradient minimization, followed by simulated 
annealing [(24); starting temperature, 500 K; final temperature 300 K], then another 100 
cycles of conjugate gradient minimization, and (iii) the same procedure as in ii, but using a 
starting temperature of 1000 K. During simulated annealing and energy minimization, the Ca 
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carbons (except for residues 50—72) were restrained to their initial crystallographic positions 
by a harmonic psuedopotential with a force constant of 50 kcal/mol. The justification for 
restraining all Ca atoms outside of the loop is the 10-year history of FBPase crystal 
structures, which collectively reveal only small changes in the protein conformation outside 
of Loop 52—72. 
Results 
Modeling of FBPase Mutants— A structural overview of the region of interest is provided in 
Fig. 1. The main chain <|> angle of Lys50 differs significantly in the T- and R-states, neither 
value being compatible with that of proline, where <f> must be close to -60°. Insertion of 
proline then, results in an initial model with poor stereochemistry at position 50. Energy 
minimization alone and energy minimization with simulated annealing at a starting 
temperature of 500 K (protocols i and ii of the experimental section) leave the <|> angle of 
Pro50 some 30° away from its preferred value in both the T- and R-states. Further 
improvement in the stereochemistry of Pro50 requires a starting temperature of 1000 K in 
simulated annealing (protocol iii of the experimental section), the consequence of which is a 
significant drift of the Loop 52—72 away from either its T- or R-state conformations. 
Evidently, proline at position 50 is incompatible with the T-state, disengaged and R-state, 
engaged loop conformations. 
Proline at position 51, on the other hand, is less disruptive. The <(> angle of residue 51 
is near -60° in both the R- and T-states of FBPase. Backbone amide 51 hydrogen bonds with 
backbone carbonyls 47 and 48 in the R-state and backbone carbonyl 46 in the T-state. 
Proline substitution at position 51 clearly disrupts the hydrogen bonds in both the R- and T-
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states. Moreover, the C^-atom of proline makes close contacts of 1.9 and 1.8 Â with 
backbone carbonyls 48 (R-state) and 46 (T-state), respectively. Either energy minimization 
alone or energy minimization with simulated annealing (initial temperature, 500 K) relaxes 
the contact in the R-state (the loop remains engaged with the active site), by a 90° rotation of 
the plane of the polypeptide linkage between residues 47 and 48. The close contact of the T-
state remains, however, at 2.4 Â and 2.8 À after modeling protocols i and ii, respectively. 
Contacts from within the subunit and from the neighboring subunit constrain the T-state 
conformation of residues 52—57 (Fig. 1). Furthermore, as backbone carbonyl 46 is an 
integral part of helix H2, it cannot relieve its close contact with Pro51 by a rotation of its 
polypeptide linkage. Hence, proline at position 51 probably increases the internal energy of 
the T-state, destabilizing it relative to the R-state of FBPase. 
Expression and Purification of Wild-type and FBPase Mutants— Mutant and wild-type 
FBPases behaved identically throughout purification, including gel exclusion 
chromatography. The wild-type and mutant enzymes were at least 95% pure with no 
evidence for proteolysis on the basis of SDS-PAGE. 
Secondary Structure Analysis—The CD spectra of wild-type FBPase in the T- and R-states 
diverge minimally, but reproducibly in the vicinity of 210 nm (17). The CD spectra of the 
Ala51-»Pro, Lys50-»Pro/Tyr57-»Trp and wild-type FBPases superimpose in the presence of P, 
(5 mM), F6P (5 mM) and saturating Mg2+ (5 mM for wild-type and Alasl-»Pro enzymes, 35 
mM for Lys50-»Pro/Tyr57-»Trp). The addition of AMP (200 |iM) to wild-type enzyme 
produced small changes in the CD spectrum near 210 nm, as noted above, but caused no 
change in the CD spectra of the Lys50-*Pro/Tyrs7-»Trp and Ala5l-»Pro enzymes. 
(Concentrations of AMP in excess of200 fiM degraded CD spectra due to the elevated 
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absorbance of radiation). The CD spectra of the Lys50-»Pro mutant also differ from the 
corresponding wild-type spectra (Fig. 2). The CD spectrum of the LysS0-»Pro mutant does 
not change in the presence of P, (5 mM), F6P (5 mM), and saturating Mg2+ (50 mM), in the 
presence or absence of AMP (200 pM). 
Catalytic Rates, Michael is Constants for Mg1* and FI6P2, and if -activation— Initial-rate 
kinetics employ maximal substrate concentrations, sufficient to saturate the active site, but 
low enough to avoid substrate inhibition. The ratio of catalytic rate constants at pH 7.5 and 
9.6 are comparable for wild-type and Alasl-»Pro FBPases (Table I), both consistent with 
reported activity ratios for an FBPase free of proteolysis. The activity ratio, however, for the 
Lys50-»Pro and Lys50->Pro/Tyr57-»Trp mutants are low, but as discussed below, the low 
value does not stem from limited proteolysis of that mutant. 
All enzymes have comparable Km values for FI6P2 (Table I), but beyond this the 
quantitative similarities end. Under standard conditions of assay for the wild-type enzyme (5 
mM Mg2+, 20 |iM FI6P2, pH 7.5), the mutation of Lys50 to proline results in a 40-fold loss in 
specific activity. The decline in specific activity, however, is due primarily to a 15-fold 
increase in the Ka for Mg2+ for the Pro50 mutant. The t value of the Pro50 mutant, saturated 
with Mg2+, is one-third of that of the wild-type enzyme. The Hill coefficients for Mg2+ for 
the Alasl-»Pro, Lys50-»Pro/Tyr57-*Trp, and wild-type enzymes are similar, but is reduced 
significantly in the Lys^-»Pro mutant. Potassium ion activation is retained in the Ala51-•Pro 
and Lys50-*Pro/Tyr57-»Trp mutants at levels comparable to that of the wild-type enzyme, but 
is abolished altogether in the Pro50 mutant. 
Kinetics of AMP Inhibition— Concentrations of AMP needed for 50% inhibition increase 
280-, 8000-, and 400-fold relative to that of the wild-type enzyme for the Ala5l->Pro, 
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Lys50-»Pro, and Lys50-»Pro/Tyr57-»Trp mutants, respectively (Table I, Fig. 3). Additionally, 
the Lys50-»Pro/Tyr57->Trp double mutant displays biphasic behavior toward AMP. Data of 
where v is the observed velocity at a specific concentration of AMP, VQ is the fitted velocity 
in the absence of AMP, / is concentration of AMP, and ICsq is the concentration of AMP 
which causes 50% inhibition. The exponent of 2 represents the Hill coefficient for AMP 
cooperativity, determined independently as described below. Data of Fig. 3 for 
Lys50-»Pro/Tyr57-»Trp FBPase were fit to Equation 4: 
where v, V0, and / are as above in Eq. 3, /Cso-high and /Cso-iow represent concentrations of 
AMP which cause 50% relative inhibition due to the ligation of high- and low-affinity sites, 
respectively. Ligation of the high affinity sites, as shown below, is cooperative with a Hill 
coefficient of 2, whereas the cooperativity with respect to the ligation of low affinity sites is 
an adjustable parameter (/z) in Eq. 4. The fitted value for n is 1.4. 
AMP inhibition of wild-type FBPase is non-linear and non-competitive with respect 
to FI6P2 and non-linear and competitive with respect to Mg2+. The Ala5l-»Pro mutant 
Fig. 3 for the wild-type, Ala5l-»Pro, and Lys50-»Pro enzymes were fit to Equation 3: 
Vo 
v -
(Eq. 3) 
(Eq. 4) 
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retains the non-linear, competitive relationship between AMP and Mg2+ (Fig. 4; goodness-of-
fit, 5.5%), consistent with Equation 5, 
1 1 
v V_ 
\ 
« \ 
/ + — 
K. 
(Eq. 5) 
where v, Vm, A, /, Ka, K„ and n represent, respectively, initial velocity, maximal velocity, 
Mg2+ concentration, AMP concentration, the Michaelis constant for Mg2+, the dissociation 
constant for AMP from the enzyme-AMP complex, and the Hill coefficient for AMP. The 
binding of AMP is cooperative at n=2, whereas cooperativity is absent when n=l. Data from 
the wild-type and the Ala5'-•Pro enzymes are consistent with n=2 (AMP cooperativity). 
When performed at low AMP concentrations, Lys50-»Pro/Tyr57-^rp retains the competitive 
mechanism with n=2. In contrast, AMP inhibition of the Lys50->Pro mutant fits best to a 
mechanism of non-competitive inhibition with respect to Mg2+ (Fig. 4; goodness-of-fit, 
3.1%), represented by Equation 6, 
1 I 
v V, M 
1 + 
Ku A 
] + —  
• y y 
(Eq. 6) 
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where the terms of Eq. 6 are defined as in Eq. 5, and represents the dissociation constant 
for AMP from the enzyme-Mg2+-AMP complex. The data are consistent with n=2, reflecting 
AMP cooperativity. 
In wild-type, AIa51->Pro, and Lys50-»Pro/Tyr57-*Trp FBPases the mechanism of AMP 
inhibition with respect to F16P2 is nonlinear and noncompetitive: 
where v, VM, B, /, Kb, and n are defined as above, and Ki and K» represent the dissociation 
constants for AMP from the enzyme-AMP and the enzyme-F 16P2-AMP complexes, 
respectively. The high value for IC50 associated with AMP inhibition of the Lys50-»Pro 
mutant (Table I) precludes the determination of a kinetic mechanism. 
Kinetics of F26P2 Inhibition— F26P2 is a competitive inhibitor with respect to FI6P2 for the 
position 50 and 51 mutant FBPases. The data best fit to Equation 8 (goodness-of-fit, 4.0%): 
where v, VM, /, B, Kiy and Kb are as above. The kinetic mechanism of F26P2 inhibition is the 
same for mutant and wild-type FBPases, but the K, for F26P2 is approximately 20-, 30-, and 
3-fold higher in Lys50-*Pro, Ala51-*Pro, and Lys50-»Pro/Tyr57-»Trp mutants, respectively, 
relative to the wild-type enzyme (Table I). 
F26P2 and AMP synergism— AMP and F26P2 synergistically inhibit wild-type and mutant 
FBPases (Fig. 5). For all enzymes the Hill coefficient for AMP is 2. At high concentrations 
(Eq. 7) 
(Eq. 8) 
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of F26P2 the saturation curve for FI6P2 changes from hyperbolic to sigmoidal for mutant and 
wild-type enzymes alike. 
Steady-State Fluorescence Measurements— TNP-AMP inhibits wild-type enzyme 
competitively with respect to Mg2+, and inhibits FBPase synergistically with F26P2. 
Fluorescence emission from AMP-PNP increases significantly in the presence of FBPase. In 
addition, AMP reduces the fluorescence from bound TNP-AMP, presumably through 
competition for the allosteric effector site (data not shown). TNP-AMP binds to wild-type, 
Lys50-»Pro, and Ala51-»Pro FBPases with high affinity, comparable to that of AMP. On the 
basis of fluorescence titration data (Table II), however, the Hill coefficient for TNP-AMP is 
near unity in all cases. 
FBPase has no tryptophan, so that the mutation of any single residue to tryptophan 
introduces a unique fluorophore. Fluorescence emission from tryptophan at position 57 is 
sensitive to the conformational state of Loop 52—72. The indole of Trp57 is exposed to 
solvent in the T-state, disengaged-loop conformation, whereas it resides in a hydrophobic 
pocket in the R-state, engaged-loop conformation. The Tyr57-»Trp mutant has been 
thoroughly studied by X-ray crystallography and initial velocity kinetics (25). Fluorescence 
emission spectra from the Pro50/Trp57 double mutant differ significantly from those of the 
Trp57 single mutant (Fig. 6). Fluorescence emission from the single Trp57 mutant is 
maximum in the presence of products/metals, conditions that promote the R-state, engaged-
loop conformation (9,10). The addition of AMP reduces fluorescence emission to a level 
comparable to that observed from the Trp57 mutant in the absence of products and metals 
(apo form of FBPase). In contrast the apo form of the Pro50/Trp57 double mutant has the 
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highest fluorescence emission. The addition of either product/metals or product/metals/AMP 
causes only a decrease in fluorescence emission. 
Discussion 
Low activity ratios (approximately 0.3) are a property of wild-type FBPase after limited 
proteolysis by papain or subtilisin (26). The maximum effect on the activity ratio due to 
proteolysis occurs when one subunit per tetramer is cut. Thus for wild-type enzyme an 
activity ratio of one, as observed for the Lys50-»Pro mutant, requires an equal mixture of 
intact and once-proteolyzed tetramers. Proteolysis of 1 of 8 subunits, then, could account for 
a diminished activity ratio in any FBPase. In SDS-PAGE of the Lys50-*Pro mutant, 
however, no fragments typical of proteolysis are evident. Furthermore, loss of AMP 
inhibition due to proteolysis of wild-type FBPase varies proportionately with the extent of 
subunit cleavage. The 8000-fold increase in K, for AMP far exceeds the effect on AMP 
inhibition due to proteolysis, even in a completely proteolyzed system. Hence, the kinetic 
properties of the Lys50-»Pro mutant are not the consequence of proteolysis, but rather the 
influence of a proline at position 50. 
Allosteric inhibition of wild-type FBPase by TNP-AMP is essentially identical to that 
caused by AMP, the only difference being the absence of cooperativity in the kinetics and the 
binding of the fluorescent analogue. In fact, TNP-AMP is indistinguishable from FMP in its 
inhibition and binding to wild-type FBPase. FMP also exhibits a Hill coefficient of unity 
(27), and crystal structures of complexes of FMP and AMP with human FBPase are identical 
(28). The difference in Hill coefficient may stem from subtle differences in conformation, 
evident perhaps only in partially ligated states of FBPase. Nonetheless, the fluorescence data 
clearly demonstrate tight binding of TNP-AMP and the displacement of that analogue from 
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FBPase by the addition of AMP. Hence, wild-type and Pro50 FBPases are indistinguishable 
in their binding of TNP-AMP and its displacement by AMP. 
On the basis of kinetics, however, Pro50 FBPase is altogether insensitive to AMP. 
Inhibition of the Pro50 mutant by AMP requires an 8,000-fold increase in ligand 
concentration and exhibits a different kinetic mechanism (non-competitive versus 
competitive with respect to Mg2+). The apparent change in kinetic mechanism may arise 
from the unmasking of a secondary mechanism, due to the complete loss of allosteric 
inhibition by AMP. That secondary mechanism may be the direct coordination of AMP to 
the metal-ligated active site of Pro50 FBPase. Hence, if AMP binds tightly to the Pro50 
mutant, as evidenced by the fluorescence data, but does not inhibit, then proline at position 
50 must interrupt the transmission of the allosteric signal. 
Data from kinetics indicate the disruption of Loop 52—72 as the root-cause for the 
loss of allosteric properties in Pro50 FBPase. The Ka for Mg2"1" is elevated 30-fold in the Pro50 
mutant, and Reactivation is lost. The kinetic mechanism of AMP inhibition with respect to 
Mg2+ is competitive in wild-type FBPase. Hence in wild-type FBPase, AMP elevates the 
apparent dissociation constant of metals. A greatly elevated ATa for Mg2+, accompanied by 
the complete loss of AMP inhibition, is consistent with an FBPase unable to achieve its high-
affinity state for metal cations. On the basis of recent crystal structures (10), the R-state, 
engaged conformation of Loop 52—72 represents the high-affinity state for metal cations and 
the catalytically productive state of FBPase. Pro50 FBPase then, cannot achieve a loop-
engaged conformation. 
Molecular modeling, CD spectroscopy and fluorescence-emission from Trp57 
strengthen the argument above. The mutation of Lys50 to proline destabilizes the R-state, 
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loop-engaged and T-state, loop-disengaged conformations in slow cooling/energy 
minimization protocols. The CD spectrum of Pro50 FBPase supports an altered state, 
conformational^ unresponsive to the binding of ligands. The indole group of Trp57 in the 
Pro50/Trp57 double mutant does not enter its hydrophobic pocket, as evidenced by the low 
fluorescence-emission in the presence of saturating products/metals. The several lines of 
evidence provided here, suggest Loop 52—72 in Pro50 FBPase can achieve neither its T-
state, loop-disengaged or its R-state loop-engaged conformations. The complete loss of 
allosteric inhibition in Pro50 FBPase suggests further, that Loop 52—72 is an essential 
element in the allosteric regulation of FBPase. 
The effects of the Ala51 mutation to proline are less dramatic, in harmony with the 
results of modeling and CD spectroscopy. The Pro51 mutant retains K+ activation and wild-
type affinity for divalent cations, but exhibits a significant increase in the K\ for AMP. The 
mutation evidently destabilizes the T-state, disengaged conformation of Loop 52—72 
relative to the R-state, engaged conformation, again consistent with the results of modeling. 
In that respect the Pro51 mutant and the Met71,72 double mutant (11) have similar effects on 
FBPase function. In both instances, lessened AMP inhibition probably arises from a 
perturbation in the equilibrium between engaged and disengaged loop conformations in favor 
of the engaged state. 
The Ki for F26P; increases 20- and 30-fold in the Lys50-»Pro and Ala51-»Pro mutants, 
respectively. The change in binding affinity for F26P; in these mutants must be indirect, and 
is most likely through a perturbation of conformation states accessible to Loop 52—72. The 
increase in K\ for F26P% due to loop mutations does not come with an increase in the Km for 
FI6P2, as has been observed in other mutations, which increase the K, ofF26Pz (29). The 
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observation above is consistent with findings that suggest F26P2 and FI6P2, although binding 
at the same site, evoke different conformational responses from FBPase. For instance, at 
high concentrat ions of  F26P2 the Hil l  coeff ic ient  for  AMP inhibi t ion changes from 2 toi ,  
and the saturation curve for FI6P2 changes from hyperbolic to sigmoidal (3,30). At low 
concentrations of F26P2 the Hill coefficient for Mg2+ changes from 2 to 1 (31). Lastly, F26P2 
protects FBPase from loss of AMP inhibition and catalytic activity due to modification by 
acetylimidazole, whereas FI6P2 protects only against loss of activity (31). Although a 
complete understanding of the above phenomena will come with further study, mutations of 
the loop underscore a fundamental difference in FBPase in its F26P%- and F16P2-ligated 
states. 
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TABLE I 
Kinetic parameters for wild-type and mutant forms offructose-1,6-bisphosphatase 
7.5/9.5 
ratio 
specific 
activity" 
kca«b Km-
FI6P2 
Ka-Mg2+ Hill-Mg2+ Kj-F26P2 IC50 AMPC K+ 
activation^ 
units mg 'sec ' sec"1 pM mM2 pM |iM % 
WT 3.3 35±2 22+1 1.7510.1 0.6710.04 1.910.1 0.12310.01 1.6110.05 16.810.3 
K50P 0.93 0.8510.06 6.7±0.3 2.110.2 10.710.8 1.4510.08 2.310.2 13400120 -4.3210.04 
A51P 3.2 20±1 12.410.7 2.510.2 0.810.1 2.110.2 3.410.2 46017 15.910.1 
Y57W* 3.3 38.610.1 24.0±0.1 3.39±0.1 0.5310.06 1.9±0.1 0.8410.05 8.510.4 16.610.4 
K50P/ 1.9 8.710.8 9.210.5 1.3±0.1 3.110.2 1.80±0.07 0.37±0.03 650±40f 14.610.1 
Y57W 
"Specific activity is determined at 5 mM Mg2+ and 20 pM FI6P2. 
bkcat is defined as V^x/E-r, where Et is the total enzyme concentration. 
cThe Hill coefficient for AMP ligation of high affinity sites is 2. See text for details. 
dK+ activation is the % increase in Vma*, using 150 mM KC1 vs. 0 mM KC1 at saturating Mg2+ and F16P2. 
'Data from (25). 
fThe reported value is for the high affinity site, ICso-high- ICso-iow is 28±6 mM with a Hill coefficient of 1.4. See text for details. 
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Table U 
Inhibition and binding constants for TNP-AMP for wild-type and mutant forms of 
fructose-1,6-bisphosphatase 
IC50 TNP-AMP K„ TNP-AMP 
fiM pM 
Wild-type 7.410.7 I3.1±0.6 
K50P N.D.a 14±4 
A51P N.D.a 31 ±2 
aNot determined due to weak inhibition by TNP-AMP. 
Fig. 1 Wild-type FBPase in the T- and R-states. The top illustrations show only the C3-
C4 subunit pair from the R-state (left) and T-state (right) tetramers. Loop 52—72 
from subunit C4 is represented by a bold, black line. The regions within the dashed 
boxes are enlarged below, showing the relative positions of Lys50, Ala51 and Tyr57. 
This figure was prepared with MOLSCRIPT (32) and RASTER3D (33). 
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LysSO 
AlaSl 
LysSO 
Fig. 2 CD spectra for wild-type and Lys50-* Pro FBPases. R-state, wild-type enzyme 
with reaction products and Mg2+ ( ). T-state, wild-type enzyme with reaction 
products, Mg2+ and AMP ( ). The CD spectra of the Lys50-» Pro mutant under 
either R- or T-state conditions ( — ). 
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s -10 
200 220 240 
Wavelength, nm 
260 
Fig. 3 AMP inhibition of wild-type and mutant FBPases. AMP titrations are of wild-type 
(•), Ala51-» Pro (•), Lys50- Pro/Tyr57-» Trp (•), and Lys50-» Pro (A) FBPases in 
saturating FI6P2 (20 pM) and a Mg2+ concentration equal to the Kg for Mg2+ of each 
enzyme. See text for details regarding the fitted curves. 
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1.2 
0.001 0.1 10 1000 
AM3, fjM 
1( 
Fig. 4 Kinetic mechanism of inhibition of Ala51-» Pro and Lys50-» Pro FBPases. AMP 
competes with Mg2+ in the Ala51-» Pro mutant (A). Concentrations of AMP are 0 
(•), 100 jiM (•), and 225|iM (A). AMP inhibition is noncompetitive with respect to 
Mg2+ in the Lys50-» Pro mutant (B). Concentrations of AMP are 0 (•), 10 mM (•), 
15 mM (A), and 20 mM (#). All assays are performed at saturating concentrations 
of FI6P2 (20 |iM) and at 150 mM KC1. The lines are based upon Equation 5 for (A) 
and Equation 6 for (B), using the parameters of Table I. 
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Fig. 5 F26P/AMP synergism for wild-type (A) and AlaSI-»Pro (B) FBPases. The 
concentrations of F26P% were 0 (•) and approximately 1/4 of K for F26Pa (0.03 |iM 
for wild-type FBPase and 0.86 pM for the Ala5l-»Pro mutant) (A). Assays have 
Mg2+ concentrations equal to the ATa for Mg2+ of each enzyme, and saturating levels of 
F16P2(20nM). 
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Fig. 6 Fluorescence spectra of the Trp57 and Trp^/Pro50 mutants. In all cases, 
apoenzymes are in 50 mM Hepes buffer, pH 7.5. Product complexes have 5 mM 
F6P, and 5 mM KPj with either 5 mM Mg2+or 35 mM Mg2+ for the Trp57 and 
Trp57/Pro50 mutants, respectively. A) Trp57 mutant. Apoenzyme ( ); product 
complex (. j; product complex + 400 pM AMP ( ). B) Pro50/Trp57 mutant. 
Apoenzyme ( ); product complex ( *); product complex + 20 mM AMP 
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CHAPTER 4. THE N-TERMINAL SEGMENT OF RECOMBINANT PORCINE 
FRUCTOSE-l,6-BISPHOSPHATASE PARTICIPATES IN THE ALLOSTERIC 
REGULATION OF CATALYSIS 
A paper published in the Journal of Biological Chemistry 
Scott W. Nelson, Feruz T. Kurbanov, Richard B. Honzatko, and Herbert J. Fromm 
Abstract 
Residues 1-10 of porcine fructose-1,6-bisphosphatase (FBPase) are poorly ordered or are in 
different conformations, sensitive to the state of ligation of the enzyme. Deletion of the first 
ten residues of FBPase reduces kcat by 30-fold, Mg2+ affinity by 20-fold, and eliminates 
cooperativity in Mg2+ activation. Although a fluorescent analogue of AMP binds with high 
affinity to the truncated enzyme, AMP itself potently inhibits only 50% of the enzyme 
activity. Additional inhibition occurs only when the concentration of AMP exceeds 10 mM. 
Deletion of the first seven residues reduces k^t and Mg2+ affinity significantly, but has no 
effect on AMP inhibition. The mutation of Asn9 to alanine reproduces the weakened affinity 
for Mg2+ observed in the deletion mutants, and the mutation of lie10 to aspartate reproduces 
the AMP inhibition of the 10-residue deletion mutant. Changes in the relative stability of the 
known conformational states for loop 52—72, in response to changes in the quaternary 
structure of FBPase, can account for the phenomena above. Some aspects of the proposed 
model may be relevant to all forms of FBPase, including the thioredoxin-regulated FBPase 
from the chloroplast. 
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Introduction 
Fructose-1,6-bisphosphatase (D-fructose 1,6-bisphosphate 1-phosphohydrolase, EC 
3.1.3.11; FBPase1) catalyzes the hydrolysis of fructose 1,6-bisphosphate (FI6P2) to fructose 
6-phosphate (F6P) and inorganic phosphate (Pi) (1—3). The reaction facilitated by FBPase 
is subject to hormone and metabolite regulation, the net result of which is the tight 
coordination of FBPase and fructose 6-phosphate 1-kinase activities (4). FBPase activity 
requires divalent cations, such as Mg2+, Mn2+, or Zn2+, and plots of velocity versus metal ion 
concentration are sigmoidal with a Hill coefficient of 2.0 (5—7). AMP binds cooperatively 
(Hill coefficient of 2) 28 Â from the nearest active site (8), and inhibits the enzyme, whereas 
F26Pa binds at the active site (9). Inhibition of FBPase by AMP and F26P% is synergistic. 
F26P% can lower the apparent inhibition constant for AMP by up to 10-fold (6). 
FBPase is a tetramer of identical subunits (Mr = 37,000). To a first approximation, 
these subunits lie in the same plane and occupy the corners of a square in one of the principal 
quaternary states of the mammalian enzyme (R-state). By past convention, subunit CI 
occupies the upper left-hand corner, with subunits C2—C4 following in a clockwise 
direction. AMP causes a transition from the R-state to the T-state, driving a 17° rotation of 
the C1-C2 subunit pair with respect to the C3-C4 pair about a molecular twofold axis of 
symmetry (10). Complexes of FBPase with AMP in the presence of FI6P2, F26P2 and F6P 
are all in the T-state (9,11,12), whereas in the absence of AMP, the enzyme has appeared in 
the R-state in crystal structures (13,14). 
Mutations in loop 52—72 and in the hinge preceding the loop (residues 50—51) 
greatly influence catalysis and AMP inhibition of FBPase, and together suggest the necessity 
of an engaged conformation for loop 52—72 for catalysis under physiological conditions 
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(15,16). The engaged conformation, in which loop 52—72 interacts with the active site, 
occurs in metal/product complexes of wild-type FBPase, but only in the absence of AMP 
(17). All residues of the engaged loop are in well-defined conformations, associated with 
clear electron density in crystal structures (13,14). The disengaged conformation of loop 
52—72 exists in AMP complexes of wild-type FBPase. The disengaged loop is far from the 
active site. Residues 52—60 lie near, and interact with, an adjacent subunit (C1-C2 
interaction), but residues 61—73 are disordered, with no observable electron density in 
crystal structures (14). In FBPase crystallized without metal cations (18) and in certain 
mutant forms of FBPase (to be discussed below in greater detail), loop 52—72 exists in yet 
another conformation, in which residues 54—73 are without electron density. This 
disordered state of the loop 52—72 is a manifold of closely related conformations, in which 
the loop itself interacts weakly with the rest of the enzyme. 
AMP binds between helices HI and H2 of FBPase and causes modest movements in 
both helices relative to the rest of the subunit (14). The 0.9 Â movement of helix H2 along 
its axis directly influences loop 52—72 (13), whereas the 1.5 Â movement of helix HI could 
influence loop 52—72 of an adjacent subunit (14). AMP may stabilize the disengaged 
conformation of loop 52—72 through helix HI by facilitating contacts between residues 
52—59 of the loop and residues 1—10 of the N-terminus. Residues belonging to this N-
terminal segment are either disordered (residues 1—6) or exist in different conformations in 
the R- and T-state of FBPase (residues 7—10). In addition, several of these N-terminal 
residues are conserved throughout FBPases from eukaryotes, suggesting a functional 
significance, as yet unconfirmed. 
Here we present the changes in functional properties of FBPase due to deletion and 
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point mutations in the N-terminal segment (residues 1—10). Mutations, which directly or 
indirectly influence positions 9 and 10, cause large perturbations in catalysis and/or AMP 
inhibition. A simple model, in which the quaternary states of FBPase differentially stabilize 
specific conformations of loop 52—72, accounts for the properties of wild-type and mutant 
FBPases presented here and in other studies. 
Materials and Methods 
Materials— FI6P2, F26P2, NADP+ and AMP were purchased from Sigma. DNA-modifying 
and restriction enzymes, T4 polynucleotide kinase and ligase were from Promega. Glucose-
6-phophate dehydrogenase and phosphoglucose isomerase came from Roche. Other 
chemicals were of reagent grade or equivalent. Escherichia coli strains BMH 71-18 mutS 
and XL 1-Blue came from Clontech and Stragene, respectively. The FBPase-deficient E. coli 
strain DF 657 came from the Genetic Stock Center at Yale University. 
Mutagenesis of Wild-type FBPase— Mutations were accomplished by deletion of or specific 
base changes in double-stranded plasmid using the Transformer™ site-Directed Mutagenesis 
kit (Clontech). The mutagenic primers are as follows: 10DEL, 
5'GAAGGAGATATACATATGGTCACCCTAACCCGCTTCGTCATGGAG3': 7DEL, 
5'GTTTAACTTTAAGAAGGAGATATACATAATGACCAATATCGTCACCCTAACCC 
GCCTCG3'; IlelO->Asp, 5 ACACCAATGACGTCACCC3': IlelO->Met 
5 ACACCAATATGGTCACCC3'; Asn9->Ala, 5 CCTTCGACACCGCTATCGTCACCC3': 
Thr8->Ala, 5 GGCCTTCGACGCCAATATCGTC3': Asp^Ala, 
5 CGGCCTTCGCÇACCAATATCGTC3'; Phe^Trp, 
5GACCAGGCGGCCTGGGACACCATTATC3': and Asp2->Ala, 
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5'ACATATGACGGCCCAGGCGGC3'. 
(Codons spanning deletions and codons for point mutations are underlined in bold typeface). 
The selection primer for mutagensis, which changed an original Nrul site on the plasmid into 
a Xhol site was 5 'CAGCCTCGCCTCGAGAACGCCA3 ' (digestion site underlined in bold 
typeface). The mutations and integrity of the constructs were confirmed by sequencing the 
promoter region and the entire open reading frame. The Iowa State University sequencing 
facility provided DNA sequences, using the fluorescent dye-dideoxy terminator method. 
Expression and Purification of Wild-type and FBPase Mutants— Protein expression and 
purification were performed as described previously (16). In order to avoid contamination of 
recombinant FBPase by endogenous enzyme, a FBPase deficient strain of E. coli was used in 
expression of the enzymes. Protein purity and concentration was confirmed by SDS-PAGE 
(19) and by the Bradford assay (20), respectively. The initial five amino acid residues of the 
10DEL and 7DEL mutants were determined by cycles of automated Edman degradation 
performed by the Iowa State University protein facility. 
Circular Dichroism (CD) Spectroscopy— CD spectra of wild-type and mutant FBPases were 
recorded at room temperature on a Jasco J710 CD spectrometer in a 1 cm cell, using a protein 
concentration of 0.35 mg/mL. Three scans of each spectrum were collected from 200 to 260 
nm in increments of 1.3 nm, and averaged. Each averaged spectrum was blank corrected 
using the software package provided with the instrument. 
Kinetic Experiments—Assays for the determination of specific activity, kcat, and activity 
ratios at pH 7.5 to pH 9.5 employed the coupling enzymes, phosphoglucose isomerase and 
glucose-6-phosphate dehydrogenase (1). The reduction of NADP+ to NADPH was 
monitored spectroscopically at 340 nm. All other assays used the same coupling enzymes, 
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but monitored the formation of NADPH by its fluorescence emission at 470 nm, using an 
excitation wavelength of 340 nm. All kinetic assays were performed at room temperature. 
Initial rates were analyzed using programs written either in the MINITAB language, using a 
a value of 2.0 (21) or by ENZFITTER (22). The kinetic data were fit to several models, the 
best fits being reported below. 
Steady-State Fluorescence Measurements— Fluorescence data were collected using a SLM 
8100C fluorimeter from Spectronic Instruments. The single tryptophan of the Trp6 mutant 
was excited selectively using a wavelength of295 nm. Fluorescence emission spectra were 
recorded in steps of 1 nm from 310 to 400 nm with a slit width of 2 mm for both excitation 
and emission, and represent the average of five such scans. Fluorescence from TNP-AMP 
employed excitation and emission wavelengths of400 and 535 nm, respectively. Conditions 
under which specific spectra were recorded are provided in the text and figure legends. Each 
data point for the titration experiments are an average of 15, 1-second, acquisitions. Enzyme 
concentrations ranged from 0.3 to 0.5 jxM. All spectra were corrected for dilution and inner 
filter effects (absorbance of light by AMP and TNP-AMP) using the following formula (23): 
FC=(F- B)(Vi/V0 )10(OD "+OD - ^  (Eq. 1) 
where Fc is the corrected fluorescence, F is the fluorescence intensity experimentally 
measured, B is the background, V\ is the volume of the sample for a specific titration point, 
V0 is the initial volume of the sample, Aex is the absorbance at the wavelength of excitation 
(295nm for AMP and 410 for TNP-AMP), and Aem is the absorbance at the wavelength of 
emission (535nm for TNP-AMP). As a control, ligands caused no change in fluorescence 
emission, after correction, from a solution of tryptophan (100 gM) in Hepes buffer (20 mM, 
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pH 7.5). 
TNP-AMP titration data were analyzed by non-linear least squares fits, using the 
following equation: 
AF _(*F tmx/F0)*L" 
f. (Eq.2) 
where AFmax is the change in fluorescence caused upon addition of ligand L, Fa is the 
fluorescence in the absence of ligand, K<\ is the dissociation constant, and n is the Hill 
coefficient. 
Results 
Expression, Purification, and Secondary Structure Analysis of Wild-type and Mutant 
FBPases—Wild-type and mutant FBPases have identical mobilities in chromatographic and 
electrophoretic separations, and are at least 95% pure by SDS-PAGE. The pH 7.5/9.5 
activity ratios of mutant enzymes (excluding the 7DEL and 10DEL mutants) indicated the 
absence of proteolyzed enzyme. Results from amino acid sequencing of the 7DEL and 
10DEL mutants are consistent with their cDNA, except for the absence of the N-formyl 
methionine. Furthermore, the sequencing data revealed a single N-terminus with no 
background signal indicative of proteolysis. The CD spectra of wild-type and mutant 
FPBases were essentially superimposable from 200 to 260 nm (data not shown). 
Catalytic Rates and Michaelis Constants for Mg*+ and F16P2 for Wild-type and Mutant 
FBPases—Initial rate kinetic studies employed substrate concentrations, saturating in FI6P2 
(20 (iM) and Mg2+ (10 times ATa-Mg2+), but not so high as to cause inhibition. The deletion 
mutants have a decreased turnover relative to wild-type FBPase, reducing k&t by 4- and 28-
fold for the 7DEL and 10DEL mutants, respectively (Table I). These deletions also caused a 
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20-fold increase in the Ka for Mg2+ and eliminated (10DEL) or reduced (7DEL) Mg2+ 
cooperativity. The 7DEL and 10DEL mutants did not influence the Km for FI6P2. Single 
point mutations had little affect on £Cat relative to the wild-type enzyme, the mutant 
Asn*-»Ala decreased Mg2+ affinity and reduced metal cooperativity. Other point mutations 
cause only minor changes in kinetic parameters, except for (in some cases) the K, for AMP. 
AMP Inhibition of Wild-type and FBPase Mutants—AMP allosterically inhibits FBPase (5). 
Complete AMP inhibition of Ile10->Asp and 10DEL FBPases requires approximately 1500-
fold more AMP than for the wild-type enzyme. In addition, AMP inhibition is biphasic (Fig. 
2). The data presented in Fig. 2, except that for the Ilel0->Asp and 10DEL FBPases, were fit 
to Equation 3: 
Vo 
v -
1 + 
\ n\ 
\IC50J 
(Eq. 3) 
where v is the observed velocity at a specific concentration of AMP, V0 is the fitted velocity 
in the absence of AMP, I is the concentration of AMP, ICso is the concentration of AMP 
which causes 50% inhibition and n is the Hill coefficient. The biphasic curves of the 
Ilel0->Asp and 10DEL mutants were fit to Equation 4: 
Vo v = 
1 + 
I V 
50-high ) IC, 50-low J 
(Eq. 4) 
where v, V0, and / are as above in Eq. 3, /Cso-high and ICso-iow represent concentrations of 
AMP which cause 50% relative inhibition due to the ligation of high- and low-affinity sites, 
respectively. Ligation of the high affinity sites, as shown below, is cooperative with a Hill 
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coefficient of 2, whereas the cooperativity with respect to the ligation of the low affinity sites 
is an adjustable parameter (n) in Eq. 4. The fitted value for n is 0.68±0.09 and 0.39±0.05 for 
the lie10-» Asp and 10DEL enzymes, respectively. The positive cooperativity for the high-
affinity interaction of AMP (the exponent for the ///C5o.high term is 2) is justified by the 
analysis of kinetics data using low concentrations of AMP (0—10 gM). These (as well as 
data for FBPases which do not exhibit biphasic inhibition by AMP), fit very well to Eq. 5 
(goodness of fit between 2.6 and 5.3%) 
1 
r 
v V 
m 
K ( 
1+- a 
rn 
K. U 
(Eq. 5) 
where v, Vm, A, /, Ka, K» and n represent, respectively, initial velocity, maximal velocity, 
Mg2+ concentration, AMP concentration, the Michaelis constant for Mg2+, the dissociation 
constant for AMP from the enzyme-AMP complex, and the Hill coefficient for AMP. All 
mutants (save 10DEL) exhibited both Mg2+ and AMP cooperativity (/z=2). The 10DEL 
mutant retained AMP cooperativity (n=2), but Mg2+ cooperativity was eliminated (%=!/ 
F26P2 Inhibition of Wild-type and Mutant FBPases—F26P2 is a substrate analog, which 
binds at the active site of the enzyme. The ATi's for F26P2 listed in Table I were determined 
by fitting the data (not shown) to Equation 2, a model for linear competitive inhibition 
(goodness of fit between 2.1 and 3.6%): 
1 1 
M 
1 + K > 
B 
1 + 
K. 
\ 
i J J 
(Eq. 6) 
where v and Vm are as above, / is the concentration ofF26Pz, B is the concentration of FI6P2, 
Kb is the Michaelis constant for FI6P2, and Af, is the dissociation constant for F26P2 from the 
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F26P2-enzyme complex. The mechanism of F26Pz inhibition is the same for all mutant and 
the wild-type FBPases. 
Fluorescence Emission from Phe6—>Trp and TNP-AMP—As wild-type FBPase has no 
tryptophan residues, the substitution tryptophan for phenylalanine at position 6 introduces a 
unique spectroscopic probe. The kinetic properties of Phe6->Trp FBPase are nearly identical 
to those of the wild-type enzyme (Table I). Furthermore, the fluorescence emission spectrum 
of the Phe6->Trp mutant changes by only 7% in its emission maximum in the presence and 
absence of saturating AMP, with no observable change in the wavelength of maximum 
emission. 
The fluorescent AMP analogue, TNP-AMP, and AMP inhibits wild-type FBPase by 
identical kinetic mechanisms, with nearly identical kinetic parameters (16). TNP-AMP has 
the advantage compared to AMP of exhibiting a significant increase in fluorescence emission 
upon its binding to the allosteric pocket of FBPase. Hence, for mutants of FBPase which 
exhibit a significant loss in AMP-inhibition due to mutation, one can use TNP-AMP to 
distinguish whether the change is due to impaired binding, or to an impaired mechanism of 
allosteric inhibition. In the cases of the 10DEL (Fig. 3) and Ile10->Asp (data not shown) 
FBPases, dissociation constants for TNP-AMP are comparable to that determined for the 
wild-type (16). 
Discussion 
Crystal structures of FBPase from mammalian sources and the chloroplast have little 
or no electron density for the N-terminal region of the enzyme. Yet certain amino acids in 
this region, particularly residues 9—10, are conserved over a wide range of organisms. As 
porcine FBPase has no tryptophan, incorporation of a tryptophan for Phe6 introduces a 
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unique spectroscopic probe. The functional properties of Phe6->Trp FBPase are comparable 
to those of the wild-type enzyme, and fluorescence emission in the presence and absence of 
AMP is about the same. Evidently, the first six residues of porcine FBPase have no 
functional role in catalysis or metabolite-regulation of catalysis. 
Position 7 may be the first residue from the N-terminus to directly or indirectly 
influence the functional properties of FBPase. Asp7 is the first residue defined by electron 
density in crystal structures of wild-type FBPase (14). The 7DEL construct exhibits 
significant changes in functional properties (Table I), in particular /fa-Mg2+ is elevated 15-
fold relative to that of wild-type FBPase. Asp7->Ala FBPase, however, has functional 
properties similar to those of the wild-type enzyme. Hence, the functional changes due to the 
7DEL construct may be the consequence of an indirect perturbation on the conformation of 
residues 9—10 and/or the conformational properties of loop 52—72 in the R-state (AMP 
absent). Interestingly, the mutation of the Lys50 to proline (a hinge element for loop 52—72), 
eliminates AMP inhibition by the disruption of the allosteric mechanism, and also causes a 
15-fold elevation in /fa-Mg2+ (16). Other mutations in the segment 50—55 cause little effect 
on AMP inhibition, but increase /fa-Mg2+ by 10-fold or more (Iancu, Fromm, and Honzatko, 
unpublished). 
The impact of the 10DEL construct on the functional properties of FBPase is even 
more extreme than is that of the 7DEL mutant. The low pH activity ratio is consistent with 
the effects of the mutation of Lys50 to Pro (16) and of the truncation of 25 residues from the 
N-terminus by proteolysis of FBPase (24). The low pH-activity ratio could result from the 
proteolysis of loop 52—72 (25); however, N-terminal sequencing of the 10DEL mutant 
excludes this possibility. Instead, the 15-fold increase in /fa-Mg2+ and the 30-fold decrease in 
Act is consistent with the failure of loop 52—72 to achieve an engaged conformation in the 
R-state of the 10DEL construct. The effects of the 10DEL mutant can be explained in part 
by the side-chain at position 9. Asn9-»Ala FBPase exhibits a 10-fold increase in its Afa-Mg2+, 
but no change in Arcat or the pH-activity ratio relative to the wild-type enzyme. In R-state 
crystal structures, Asn9 hydrogen bonds with Arg15 (Fig. 4). The Asn9-Arg15 interaction 
probably stabilizes residues 7—11 in their R-state conformation. These residues pack 
between Helix 3 and loop 187—194. Loop 187—194 interacts through hydrogen bonds and 
nonbonded contacts with hinge residues preceding loop 52—72 (Fig. 4). The loss of the 
Asn9-Arg15 hydrogen bond may lead to a long-range conformational change, which 
destabilizes the engaged conformation of loop 52—72. Indeed, the disordered conformation 
of loop 52—72 appears hand-in-hand with disorder in residues 1—11 in R-state crystal 
structures (9,18). 
Unlike the 7DEL construct, which has little effect on allosteric inhibition by AMP, 
the 10DEL mutation significantly alters the maximum level of AMP inhibition. The 25-
residue, truncated form of FBPase is not inhibited by AMP (24). As some of the 25 residues 
are part of the AMP-binding pocket (14), the effect of limited proteolysis is of little surprise. 
In contrast, the first 10 residues are remote from the site of AMP binding, and indeed, TNP-
AMP binds with nearly identical affinity constants to 10DEL and wild-type FBPases. 
Changes in the functional properties due to the 10DEL mutant, then, must result from 
perturbations in the allosteric mechanism of AMP inhibition. Although no single point 
mutation reproduced the functional properties of the 10DEL construct in the absence of 
AMP, the mutation of He10 to aspartate reproduced the phenomenon of 50% maximal 
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inhibition by AMP. As noted below, the hydrophobic side chain at position 10 is critical to 
the stability of the disengaged conformation of loop 52—72 in the T-state. 
The following model is a basis for understanding AMP inhibition in wild-type 
FBPase and in mutant FBPases. Hereafter, T-state and R-state refer to quaternary 
arrangements of subunits in FBPase, distinguished by the 17°-rotation about a molecular 
symmetry axis. In addition, the subunits in the T- and R-states can adopt different tertiary 
conformations, the most significant of which involve conformational changes in loop 52— 
72. In the T-state of wild-type FBPase, loop 52—72 is in the disengaged conformation. The 
T-state subunit arrangement stabilizes the disengaged conformation by interactions, which 
involve residues 50—60 of subunit Cl with residues 187—194 and 9—11 of subunit C2 
(Fig. 5). Point mutations in these structural elements profoundly influence AMP inhibition 
(16,26,27), AMP cooperativity (26,27), F26P2 inhibition (16,27), and/or metal affinity (16). 
The R-state subunit arrangement does not stabilize the disengaged loop conformation. As a 
consequence loop 52—72 occupies an engaged conformation or a disordered conformation. 
The engaged conformation was first observed in the context of a product/Zn2+-complex of 
the wild-type enzyme (13). The disordered conformation of loop 52—72 appears in FBPase 
structures crystallized in the absence of metal activators (18). 
Catalysis occurs at neutral pH, if loop 52—72 can cycle between its engaged and 
disordered conformations. A loop that is always engaged is a dead-end complex. A loop that 
cannot achieve the engaged conformation results in low metal affinity and little or no activity 
at neutral pH. Assuming loop 52—72 exchanges between its engaged and disordered 
conformations, the free energy differences between these conformational states must be 
small, that is the R-state maintains small free-energy differences between disordered and 
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engaged conformations of loop 52—72. In contrast, the T-state subunit arrangement 
selectively stabilizes a new conformation for loop 52—72 (disengaged conformation), which 
de-populates the disordered/engaged loop conformations. The decline in the catalytic rate of 
T-state FBPase is directly related to the differences in free energy between the 
engaged/disordered loop conformations and the disengaged loop conformation. For the wild-
type enzyme, the free energy difference is large, hence little or no catalysis occurs. For 
specific mutants of FBPase which selectively destabilize the disengaged loop conformation, 
the free energy difference is less, the engaged/disordered loop conformations are more 
populated, and hence a measurable level of catalysis occurs. Biphasic AMP inhibition 
should appear whenever a mutation selectively destabilizes the disengaged loop 
conformation of the T-state. FBPase mutants with biphasic AMP inhibition (Lys42-» Ala, 
Glu192-»Ala, Glul92-»Gln, Lys50-»Asn, Lys50-»Pro/Tyr57-»Trp, and He'0-»Asp) exhibit 
plateau activities, which vary from 10% to 70% of the full activity (16,26,27). As suggested 
by Kantrowitz and colleagues (28), the activity most likely comes from FBPase in the T-state 
subunit arrangement. Here we add that some fraction of the mutant FBPases have 
engaged/disordered loop conformations in the presence of AMP, which are responsible for 
the observed turnover. The free-energy relationships of the model are summarized in Fig. 6. 
From the model above, mutant FBPases with biphasic AMP inhibition must have a 
less-stable, disengaged conformation of loop 52—72 in the T-state. In fact, structural 
evidence supports this claim. The disengaged loop in the T-state of wild-type FBPase has 
interprétable electron density up to residue 60, with the residues 50—60 participating in 
interactions across the C1-C2 subunit interface (14). The mutation of Lys42 to alanine results 
in biphasic AMP inhibition with 70% relative activity at the plateau (26). The crystal 
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structure of the AMP complex of the Lys42-»Ala mutant is in the T-state, but loop 52—72 is 
poorly ordered from residues 54 to 72 (28). In the crystal structure of the AMP complex of 
lie10-»Asp (Iancu, Fromm, and Honzatko, unpublished) the enzyme is again in the T-state, 
and loop 52—72 is without electron density from residues 54 to 72. Hence, loop 52—72 in 
the Ala42 and Asp10 mutants is not in the disengaged conformation of wild-type FBPase, but 
rather in a disordered conformation, similar to that of the R-state apoenzyme. If the 
disengaged structure is de-populated in favor of disordered conformations, then perhaps 
under the appropriate conditions an engaged conformation for loop 52—72 may occur in the 
T-state of such mutants. 
The thioredoxin-mediated formation of a disulfide bond between Cys153 and Cys173 in 
chloroplast FBPase (29) putatively stabilizes the position of a loop that excludes the binding 
of metal activators and the engaged conformation of loop 61—81 (which corresponds to loop 
52—72 of mammalian FBPase) (30). FBPase from the chloroplast evidently does not bind 
AMP (30,31). Yet existing crystal structures of reduced and oxidized chloroplast FBPase 
have nearly the same quaternary arrangement of subunits, resembling most closely the T-
state of mammalian FBPase. Hence, as illustrated by FBPase from the chloroplast, a T-state 
subunit arrangement by itself does not exclude catalysis. Interestingly, position 18 of the 
chloroplast enzyme, which corresponds to position 10 of mammalian FBPase, is isoleucine, 
this residue being widely conserved amongst FBPases. Furthermore, in the inactive, 
oxidized form of chloroplast FBPase, loop 61—81 (corresponding to loop 52—72 of the 
mammalian enzyme) is in the disengaged conformation (30), whereas the equivalent loop in 
the active, reduced form of chloroplast FBPase is in the disordered conformation (32). 
Evidently, oxidation and reduction of the disulfide bond in chloroplast FBPase influences the 
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relative stability of the disengaged loop-conformation in a manner similar to that of AMP 
mammalian FBPases. The observation of corresponding conformational states in 
mammalian and chloroplast FBPases, infers a common, early mechanism of FBPase 
regulation, that has diverged through evolution. 
Abbreviations 
FBPase, fructose-1,6-bisphosphatase; FI6P2, fructose 1,6-bisphosphate; F6P, fructose 6-
phosphate; F26Pz, fructose 2,6-bisphospate; Pj, orthophosphate; CD, circular dichroism; 
TNP-AMP, 2,-(or-3')-0-(trinitrophenyl) adenosine ^'-monophosphate. 
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Table I 
Kinetic parameters for wild-type and mutant forms offructose-1,6-bisphosphatase 
FBPase pH kcat Km-FBP Ka-Mg2+ Hill-Mg2+ Kj- IC50-AMP Kj-AMP 
ratio F26P2 
sec"1 jaM mM2 nM pM yM2 
WT 3.3 2211 1.810.1 0.6710.04 1.910.1 12315 1.6110.05 1.1910.06 
10DEL 0.5 0.70±0.1 1.8310.07 13.210.1" 0.981.02 4513 3.210. lb 0.4910.03 
7DEL 1.3 5.810.1 0.7210.06 11.210.7 1.4010.08 220110 0.8010.04 0.4210.02 
D2A 3.7 18.810.5 2.0310.08 1.2110.05 1.6210.06 6413 1.910.2 1.510.1 
F6W 3.3 18.010.5 1.5810.06 0.9910.05 1.6710.07 110110 2.8710.09 0.7810.03 
D7A 2.6 11.310.6 1.810.1 1.310.1 1.5610.09 6014 0.7010.01 0.6210.03 
T8A 4.6 25±2 2.110.1 1.410.1 1.710.1 17318 0.8710.03 0.3610.03 
N9A 3.3 21.210.9 0.6310.03 6.610.3 1.5010.06 7611 1.0810.03 0.5910.04 
110M 3.1 15.310.6 2.010.1 1.2810.04 1.7110.04 7617 2.8510.06 0.5710.05 
I10D 3.0 16.710.4 1.210.1 0.5610.05 2.010.1 8118 2.7510.09" 2.710.2 
aKa for 10DEL is reported in mM. 
bData reported for the high affinity site, IC50 for low affinity sites > 20 mM 
Fig. 1 AMP inhibition of wild-type and mutant FBPases. AMP titrations are of wild-type 
(•), Ile'°->Asp (•), and 10DEL (A) FBPases in saturating F16P2 (20 |iM) and a 
Mg2+ concentration equal to the Ka for Mg2+ of each enzyme. See text for details 
regarding the fitted curves. 
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Fig. 2 Kinetic mechanism of AMP inhibition of Ilel0-»Asp and 10DEL FBPases. AMP 
competes with Mg2+ in both the 10DEL (A) and Ilel0->Asp (B) mutants. 
Concentrations of AMP are (A) 0 (•), 1 pM (#), and 1.5 pM (A) and (B) 0 (•), 2 
pM (•), and 4 pM (A). 
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Fig. 3 TNP-AMP titration of the 10DEL mutant. Fluorescence of TNP-AMP observed in 
the presence of 0.5 pM 10DEL. A wavelength of400 nm was used for excitation and 
fluorescence emission was monitored at 535 nm. 
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Fig. 4 Structural elements important to allosteric regulation in the R-state of FBPase. 
The tetramer as viewed down one of its three, mutually perpendicular symmetry axes 
in the R-state (top). Loop 52—72 is in the engaged conformation. Residues near the 
hinge of this loop in subunit C4 pack against loop 182—194 of subunit C3, which in 
turn pack against residues 7—11 of the N-terminal segment preceding Helix HI of 
subunit C3 (bottom). Residues 7—11 lie in a groove bordered by Helix H3 of subunit 
C2 and loop 182—194 of subunit C3. Orientations of top and bottom illustrations are 
the same. This illustration was drawn with MOLSCRIPT (33). 
Asn 83| 
Ile 190 
Ile idxvAsn 9 
,sp 187 
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Lys 50 
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<Val 196 Met 185 
Fig. 5 Structural elements important to allosteric regulation in the T-state of FBPase. 
Shown here are segments of two polypeptide chains (residues 9—89) viewed down 
an axis of molecular twofold symmetry toward the interface buried between subunits 
Cl—C2 and subunits C3—C4 (top). The side-chain of lie10 from subunit C2 makes 
nonbonded contacts with Thr 12 and lie194, both from subunit C2, and Tyr57 and lie59, 
both from loop 52—72 of subunit Cl (bottom). Orientations of top and bottom 
illustrations are the same. This illustration was drawn with MOLSCRIPT (33). 
113 
Subunit C1 
Subunit C2 
Leu 56 
Ile 53 
Ile 190 
Ala 54 Tyr 57 
Ile 59 
Ile 194, 
Ile 10 
iThr 12 
Fig. 6 Changes in relative free energy levels of three loop conformations in the R- and 
T-states of wild-type and Asp10 FBPases. Bold lines indicate the energies of the 
engaged and disengaged conformations of loop 52—72, whereas the bundle of fine 
lines represents the disordered loop, which is in a manifold of conformational states 
with nearly equivalent free energies. In the wild-type enzyme, the R- to T-transition 
selectively stabilizes the disengaged conformation of loop 52—72 over the engaged 
and disordered conformational states. In the Ile'°->Asp mutant, the T-state does not 
stabilize a disengaged conformation for loop 52—72. The separation in free energy 
between the engaged conformation and the disordered conformation in the T-state 
(AG in figure), may influence the observed level of catalytic activity in the presence 
of saturating AMP. 
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CHAPTER 5. SPONTANEOUS SUBUNIT EXCHANGE IN PORCINE LIVER 
FRUCTOSE-l,6-BISPHOSPHATASE 
A paper published in FEBS Letters 
Scott W. Nelson, Richard B. Honzatko, and Herbert J. Ffomm* 
Abstract 
No evidence to date suggests the possibility of subunit exchange between tetramers of 
mammalian fructose-1,6-bisphosphatase. An engineered fructose-1,6-bisphosphatase, with 
subunits of altered electrostatic charge, exhibits spontaneous subunit exchange with wild-
type enzyme in the absence of ligands. The exchange process reaches equilibrium in 
approximately 5 hours at 4° C, as monitored by non-denaturing gel electrophoresis and anion 
exchange chromatography. Active site ligands, such as fructose 6-phosphate, abolish subunit 
exchange at the level of the monomer, but permit dimer-dimer exchanges. AMP, alone or in 
the presence of active site ligands, abolishes all exchange processes. Exchange phenomena 
may play a role in the kinetic mechanism of allosteric regulation of fructose-1,6-
bisphosphatase. 
Introduction 
Fructose-1,6-bisphosphatase (D-fructose 1,6-bisphosphate 1-phosphohydrolase, EC 
3.1.3.11; FBPase1) catalyzes the hydrolysis of fructose 1,6-bisphosphate (FI6P2) to fructose 
6-phosphate (F6P) and inorganic phosphate (Pj) [1-3]. The futile cycle defined by FBPase 
and fructose 6-phosphate 1-kinase is subject to strict hormone and metabolite regulation [4]. 
Inhibition of FBPase by AMP and F26Pz is synergistic [5]. AMP binds cooperatively (Hill 
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coefficient of 2), approximately 30 Â from the nearest active site [6], whereas F26P% binds at 
the active site [7], 
FBPase in crystals is a tetramer of identical subunits (Mr=37,000), and exists in one 
of two conformational states called R and T. Subunits of the R-state enzyme, which 
crystallizes in the presence of active site ligands, lie approximately in a plane. By past 
convention [8], the subunits of the tetramer are named as in Fig. 1. A 17°-rotation of the 
subunits C1-C2 with respect to subunits C3-C4 about a molecular twofold axis of symmetry 
transforms the R-state into the T-state conformer [9]. Complexes of FBPase with AMP in 
the presence of FI6P2, F26Pz and F6P are all in the T-state [10-12], whereas in the absence 
of AMP, the crystalline enzyme is in the R-state [13-15]. 
Analytical ultracentrifugation, using protein or product absorbance for detection [16-
18], indicates only FBPase tetramers, the one exception being a thermophilic FBPase dimer 
[19]. In addition, FBPase exhibits retention times in size exclusion chromatography, which 
are consistent with a tetramer [20]. 
Subunit exchange is an alternative to analytical ultracentrifugation in monitoring the 
dissociation of oligomeric proteins into subunits [21-23]. An increasing number of proteins 
have been identified that undergo subunit exchange reactions. Hemoglobin, thymidylate 
synthetase, GroES, alpha-crystallin, smooth muscle myosin filaments, adenylosuccinate 
lyase, and adenylosuccinate synthetase exhibit subunit exchange in the absence of 
dénaturants [24-30]. Apart from the above, most oligomeric proteins require dénaturants, 
such as urea or extremes in pH, or the use of hydrostatic pressure to induce subunit exchange 
[31-33]. In some instances, most notably lactate dehydrogenase, hybrids between two 
isozymes form in vivo [34]. In order to probe whether subunit exchange occurs in FBPase, a 
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mutant enzyme was engineered that differs from the wild-type enzyme in its electrostatic 
charge. Non-denaturing gel electrophoresis and anion-exchange chromatography reveals 
spontaneous subunit exchange between the engineered and wild-type FBPases. 
Materials and Methods 
Catalysis and AMP inhibition are sensitive to mutations near the N-terminus of recombinant 
porcine FBPase [35]. Hence, initial efforts focused on the addition of charged residues to the 
C-terminus of the polypeptide chain. C-terminal additions of 10 histidines or 10 glutamates, 
however, resulted either in the expression of unstable proteins or proteins that behaved 
poorly in chromatographic separations. The mutation of surface lysines at positions 268,269 
and 272 to glutamate provided a stable and easily purified FBPase. Specific base changes in 
double-stranded plasmid employed the Quickchange™ Mutagenesis kit (Stratagene). The 
procedure involves 20 cycles of linear PCR using two complementary mutagenic primers 
(listed below). The mixture is then treated with Dpn I restriction enzyme in order to remove 
parental DNA, leaving only mutated nicked circular DNA strands. The nicked DNA is then 
transformed into XL 1-Blue competent cells for amplification of the mutant double stranded 
plasmid DNA. Two sets of primers were used sequentially to produce the triple mutant. 
K268E and K269E were introduced using a forward primer with the sequence: 5'-
GGGATCTTTATGTACCCAGC-
AAACGAGGAAAGCCCCGAAGGAAAGTTAAGACTGC-3 '. The forward primer for the 
K272E mutant was: 5'-
CCCAGCAAACAAGAAAAGCCCCGAAGGAAAGTTAAGACTGCT-AT-3 '. The 
reverse primers used in the mutagenesis reaction were the complement of the forward 
primers listed above. Mutations, and the integrity of the resulting gene, were confirmed by 
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sequencing the promoter region and the entire open reading frame. The Iowa State 
University sequencing facility performed all DNA-sequencing, using the fluorescent dye-
dideoxy terminator method. 
Protein expression and purification were as described previously [36]. FBPase-
deficient Escherichia coli were used for the expression of wild-type (recombinant porcine 
liver) and engineered (lysines 268,269 and 272 to glutamate) FBPases. Protein purity and 
concentration throughout the purification procedure was monitored by sodium 
dodecylsulfate-PAGE [37] and Bradford assays [38], respectively. 
CD spectra of wild-type and engineered FBPases were collected at room temperature 
on a Jasco J710 CD spectrometer in a 1 cm cell, using a protein concentration of 0.30 
mg/mL. Spectra were an average of three independent scans collected from 200 to 260 nm in 
increments of 1.3 nm. Each spectrum was blank-corrected using software provided with the 
instrument. 
Assays for the determination of specific activity, A^at, and activity ratios at pH 7.5 and 
9.5 employed the coupling enzymes, phosphoglucose isomerase and glucose-6-phosphate 
dehydrogenase (Roche) [1]. The reduction of NADP+ to NADPH was monitored by 
absorbance change at 340 nm. All other assays used the same coupling enzymes, but 
monitored NADPH production by its fluorescence emission at 470 nm with an excitation 
wavelength of340 nm. All kinetic assays were performed at 22° C. Initial kinetic rates were 
analyzed by programs written in MINITAB, using an a value of 2.0 [39], or by the 
ENZFITTER software package [40]. Kinetic parameters and equations are provided in [36]. 
Non-denaturing PAGE was performed according to [37], but omitting the sodium 
dodecylsulfate and 2-mercaptoethanol from the loading and running buffers. In-gel activity 
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assays were performed as in [41]. After electrophoresis, the gel was placed on a bed of solid 
0.5% low-melting agarose (total volume 20 ml), containing 5 mM MgCl, 150 mM KC1,15 
|iM NADP+, 1 mM FBP, 10 pg/ml phosphoglucose isomersase, 5 pg/ml glucose-6-
phosphatase dehydrogenase, 0.6 jiM nitroblue tetrazolium (NBT), and 1.6 nM phenazine 
methosulfate (PMS) (all components added after agarose had cooled to 37° C). Color was 
allowed to develop at 22° C, which was then arrested after 10 to 15 minutes by the addition 
of 10% acetic acid. 
Subunit exchange reactions monitored by non-denaturing PAGE were performed in 
Hepes buffer (pH 7.5) using equal protein concentrations (0.5 mgZmL) for each enzyme and a 
temperature of 4° C. Ligand concentrations in subunit exchange reactions are in the figure 
legends. Tetramer hybrids, analyzed by anion exchange chromatography, were produced 
from a mixture of wild-type and engineered FBPases, dialyzed overnight against 20 mM 
Tris-HCl (pH 8.3) at 4° C. The hybrid mixture was then loaded onto a DEAE-HPLC column, 
and eluted by a gradient, 0 to 300 mM in NaCl. AMP was added immediately to the eluted 
hybrids, in order to arrest exchange prior to analysis by non-denaturing PAGE. 
Results 
Wild-type and engineered FBPases exhibit identical properties during purification 
except that, as anticipated, they elute at NaCl concentrations of 150 and 300 mM, 
respectively, from a DEAE-sepharose column. The wild-type and mutant enzymes are at 
least 95% pure with no evidence of proteolysis on the basis of non-denaturing-PAGE or 
sodium dodecylsulfate-PAGE. The CD spectra of wild-type and engineered enzymes, a 
measure of secondary structure, are identical to within experimental uncertainty. The Km for 
FI6P2 and K\ for F26P% for the engineered enzyme are approximately 4- and 12-fold greater 
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than that of the wild-type enzyme (Table I). All other kinetic parameters, as well as 
mechanisms of inhibition by AMP and F26Pz, are unchanged by the mutations. 
Subunit exchange between the wild-type and engineered proteins is apparent from 
non-denaturing gels. The expected pattern of five electrophoretically distinct bands represent 
wild-type.engineered subunit ratios of 4:0, 3:1,2:2,1:3, and 0:4. Subunit exchange is time-
dependent, and exhibits first order kinetics (Fig. 2A&B). The lines in Fig. 2 represent single 
exponential fits to data acquired from band densities averaged over three gels. Rate 
constants for the disappearance of wild-type and engineered homotetramers and the 
appearance of the three hybrid species are in Table 2. Incubation in 8 M urea for five 
minutes, followed by a 50-fold dilution and ammonium sulfate precipitation (the procedure 
takes a total of 10 minutes), results in a pattern identical to that observed after six hours in a 
buffer without urea (data not shown). In-gel activity assays indicate that the hybrid enzymes 
retain full activity (Fig. 2D). Additionally, the specific activity of the hybrid mixture is equal 
to that of the homotetrameric enzymes. Ligands that bind to the active site permit only 
dimer-dimer exchange (Fig. 2C), with a decreased rate constant for the formation of the 2:2 
hybrid relative to that obtained in the absence of ligands. No hybrids of any kind appear for 
up to 12 hours in the presence of AMP, or in combinations of AMP with F26Pa or F6P. 
The hybrid tetramers possess different retention times on a DEAE anion-exchange 
column, consistent with their mobilities on non-denaturing PAGE (Fig. 3). However, the 
appearance of six equally active peaks is unexpected. Non-denaturing PAGE analysis 
reveals that the peaks at 107 and 112 minutes are both 2:2 hybrids. Presumably, the spatial 
arrangement of subunits within the 2:2 hybrid affects its affinity for the DEAE column. 
Three 2:2 hybrids are possible, each differing with repsect to distances between charged 
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groups. Fushinobu and collègues also observed partial resolution of different 2:2 hybrids in 
their purification of lactate dehydrogenase hybrids [42]. Purified hybrids revert to an 
equilibrium mixture in the absence of ligands, but the addition of AMP maintains purified 
hybrids as single entities. The specific activities of all isolated hybrids, assayed within two 
minutes of elution from the anion-exchange column before the addition of AMP, are 
approximately equal to that of hybrid mixture. 
Discussion 
On the basis of steady-state kinetics the replacement of lysine at positions 268,269, 
and 272 with glutamate modestly perturbs the affinities of FI6P2 and F26Pz. The elevated 
Km for FI6P2 and K, for F26Pz in the engineered enzyme is probably due to a perturbation of 
Lys274 by the mutation of Lys272. The mutation of Lys274 to alanine results in a 20-fold 
increase in the Km of FI6P2 and a 1000-fold increase in the K, of F26P2 [43]. The mutations 
above may alter as well the exchange properties of the engineered protein. Even so, any 
observation of subunit exchange here is possible only if both the wild-type and engineered 
FBPases participate. A non-exchanging, wild-type FBPase would block the formation of 
hybrid tetramers. 
Subunit exchange can demonstrate the existence of dissociated subunits in 
equilibrium with an oligomeric protein, even when concentrations of dissociated subunits are 
vanishingly small or are in rapid exchange with the parent oligomer [21]. Data of Fig. 2 are 
compelling evidence in support of subunit dissociation/reassociation phenomena in FBPase. 
In the absence of ligands, FBPase must be in rapid equilibrium with a pool of monomers or a 
mixture of monomers and dimers. During the time course of subunit exchange in the absence 
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of ligands, the 2:2 hybrids appear first, followed by the 1:3 and 3:1 hybrids. 
Active site ligands selectively arrest exchange phenomenon at the level of individual 
subunits. After a time sufficient to achieve an equilibrium mixture of hybrids, only the 2:2 
hybrid forms in the presence of F6P, FI6P2 or F26Pz. By binding to residues from both the 
C1 and C2 subunits, the 6-phosphoryl group of active site ligands probably retards the 
dissociation of C1-C2 dimers into monomers. 
AMP prevents subunit exchange altogether. As AMP binds exclusively to one 
subunit, it cannot be involved directly in a subunit cross-linking phenomenon. The number 
of intersubunit contacts between subunits CI and C4 in the T-state conformer is greater than 
in the R-state. Thus, the stabilization of the C1-C4 interface (dimer-dimer interface) may 
impede subunit exchange. The simplest model that accounts for the exchange phenomena 
reported here is an ordered dissociation of subunits in which the enzyme must first be in the 
R-state before it can dissociate into C1-C2 dimers, followed by dissociation of C1-C2 dimers 
into monomers (Fig. 4). The dimer in the model above is an obligatory intermediate in the 
exchange of individual subunits. The data here, however, cannot unambiguously define the 
kinetic pathway of exchange. The model above is merely a plausible explanation of 
observations reported here. 
The physiological consequence of subunit exchange (even if it occurs in v/vo) is 
unclear. Although mammals have two isozymes of FBPase, there is no direct evidence 
suggesting the co-expression of both isozymes within the same cell type. If indeed isozymes 
of FBPase are segregated, then exchange cannot result in the formation of hybrids in vivo. 
No one to our knowledge has reported the isolation of FBPase hybrids from a mammalian 
tissue. Nonetheless, the similar isoelectric points and masses of the two isozymes may 
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obscure the detection of such hybrid tetramers. 
As subunit exchange occurs fairly rapidily under non-denaturing conditions, subunit 
exchange could have a bearing on the dynamics of the R- to T-state conformational change. 
More specifically, how are steric barriers at the dimer-dimer interface overcome during the 
transition between quaternary states? AMP may bind initially to an FBPase dimer (Fig. 4), 
altering its conformation so that reassociation results in a stable T-state tetramer. As AMP 
inhibition occurs rapidly, this model requires rapid dimer dissociation/reassociation. Rate 
constants for subunit exchange reported here, do not exclude this possiblity. The subunit 
exchange rate is not a measure of the rate of tetramer dissociation into dimers. The majority 
of dissociation events may result in immediate reassociation before dimer exchange occurs. 
Only occasionally will a subunit or dimer of subunits reassociate with another subunit/dimer 
from a different tetramer. If the rate of subunit dissociation is high, but that of reassociation 
still higher, the equilibrium constant will favor the tetramer, keeping dimers and monomers 
at vanishingly low concentrations. Clearly, the rapid exchange of subunits observed here 
introduces many new considerations and another level of complexity regarding the assembly 
and regulation of FBPase. 
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Table 1 
Kinetic parameters for wild-type and engineered mutants of fructose-1,6-bisphosphatase. 
FBPase pH ratio" kç,* Km-F16P2c K,-Mgz+d Hill-Mg2* Kj-F26P2c IC50-AMPd 
sec ' pM mM piM pM 
WT 3.3 22±1 1.810.1 0.67+0.04 1.910.1 0.1210.01 1.6110.05 
Eng 3.4 2112 6.610.7 0.7810.06 2.11.0.2 1.510.1 2.910.2 
"Ratio of the specific activities at pH 7.5 and 9.5. 
bSpecfic activity determined at saturating substrate concentrations divided by total protein concentration. 
'Determined at a Mg2+ concentration of 5 mM. 
^Determined at the K& of Mg2+ for each enzyme and a F16P2 concentration of 20 and 100 pM for wild-type and engineered 
FBPases, respectively. 
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Table 2 
Rate constants for hybrid tetramer formation and homotetramer disappearance. 
Subunit ratio Rate constant 
WT:Enga Hours*1 
4:0 1.3+0.1 
3:1 0.85±0.06 
2:2 1.3±0.1 
1:3 0.63+0.06 
0:4 0.95±0.05 
"Ratio of wild-type to engineered subunits in the tetramer. 
Figure 1. Quaternary conformational states of FBPase. F6P and AMP identify the 
relative positions of active and allosteric inhibitor sites, respectively. Dashed outlines 
represent binding sites on the face of the tetramer hidden from view. Distances 
between the active site of subunit C2 and the four AMP binding sites of the tetramer 
are shown. A 17°-rotation of the CI-C2 subunit pair as shown, converts the T-state 
into the R-state conformer. 
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T-state 
Figure 2. Subunit exchange between wild-type and engineered FBPases. ( A )  Time 
course of the exchange as seen by 6% non-denaturing-PAGE. Lanes 1 and 10 are 
purified wild-type and engineered FBPases, respectively. Lanes 2-9 are wild-type 
and engineered FBPases mixed at approximately equal concentrations (0.5 mg/ml) at 
the following times prior to loading the gel: 0,0.25,0.5, 1, 1.5,2,3.5, and 6 hours, 
respectively. (A) Time courses for the disappearance of homotetramers and the 
formation of hybrid tetramers, based on density scans of gels from A. The symbols 
represent (ratios listed are wild-type:3KE): (#) loss of wild-type homotetramer, (•) 
loss of 3KE homotetramer, (•) gain of 2:2 hybrid, (•) gain of 3:1 hybrid, and (O) 
gain of 1:3 hybrid. (C) The effect of ligands on subunit exchange. Lane 1 contains 
wild-type and engineered enzymes mixed just prior to loading. Lanes 2-4 have the 
two FBPases along with AMP, AMP + F6P, and AMP + F26Pz, respectively, 
incubated for 12 hours. Lane 5 has wild-type and engineered enzymes incubated for 
6 hours. Lanes 6-10 contain the two FBPases along with F6P + KPj + Mg2+, F26Pz, 
FI6P2, F6P + KPj, and F6P, respectively, incubated for 12 hours. Concentrations of 
AMP, FI6P2, F26Pz, F6P, KPj, and Mg2+ arc 1,0.5,0.2,5,5, and 5 mM, respectively. 
(D) In-gel activity assay of wild-type and engineered FBPases. Lane I has 4 |ig of 
wild-type enzyme, lanes 2 and 3 have 7.5 pg and 15 ng of the hybrid mixture, 
respectively, and lane 4 contains 4 ng of engineered FBPase. 
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Figure 3. Elution profile of a hybrid mixture from DEAE-HPLC. The number above 
each peak indicates the specific activity assayed immediately after elution and before 
the addition of AMP. 
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Figure 4. Proposed pathway for subunit exchange and the R- to T-state transformations 
in FBPase. Subunit exchange and the quaternary conformational change in FBPase 
may both proceed through a dimer. 

139 
CHAPTER 6. HYBRID TETRAMERS OF PORCINE LIVER FRUCTOSE-1,6-
BISPHOSPHATASE REVEAL MULTIPLE PATHWAYS OF ALLOSTERIC 
INHIBITION 
A paper published in the Journal of Biological Chemistry 
Scott W. Nelson, Richard B. Honzatko, and Herbert J. Fromm* 
Abstract 
Fructose-1,6-bisphosphatase is a square planar tetramer of identical subunits, which exhibits 
cooperative allosteric inhibition of catalysis by AMP. Protocols for in vitro subunit exchange 
provide 3 of 5 possible hybrid tetramers of fructose-1,6-bisphosphatase in high purity. The 
two hybrid types with different subunits in the top and bottom halves of the tetramer co-
purify. Hybrid tetramers, formed from subunits unable to bind AMP and subunits with wild-
type properties, differ from the wild-type enzyme only in regard to their properties of AMP-
inhibition. Hybrid tetramers exhibit cooperative, potent, and complete (100%) AMP-
inhibition if at least one functional AMP-binding site exists in the top and bottom halves of 
the tetramer. Furthermore, titrations of hybrid tetramers with AMP, monitored by a 
tryptophan reporter group, reveal cooperativity and fluorescence changes consistent with an 
R- to T-state transition, provided that again at least one functional AMP site exists in the top 
and bottom halves of the tetramer. In contrast, hybrid tetramers, which have functional 
AMP-binding sites in only one half (top/bottom), exhibit an R- to T-state transition and 
complete AMP-inhibition, but without cooperativity. Evidently, two pathways of allosteric 
inhibition of fructose-1,6-bisphosphatase are possible, only one of which is cooperative. 
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Introduction 
Fructose-1,6-bisphosphatase (D-fructose-1,6-bisphosphate 1 -phosphohydrolase, EC 
3.1.3.11; FBPase1) catalyzes the hydrolysis of fructose 1,6-bisphosphate (FI6P2) to fructose 
6-phosphate (F6P) and inorganic phosphate (Pj) (1,2). FBPase, a key regulatory enzyme of 
the gluconeogenic pathway, is itself regulated indirectly through the action of glucagon and 
insulin and directly by the ligation of AMP and F26P2. AMP and F26P% inhibit FBPase 
while simultaneously activating its counterpart in glycolysis, fructose-6-phosphate 1-kinase 
(3,4). AMP binds 28 Â away from the nearest active site, and non-competitively inhibits 
catalysis with respect to FI6P2, but competitively inhibits with respect to essential divalent 
cations (Mg2+, Mn2+, or Zn2+) (5-7). F26P% enhances the binding of AMP up to an order of 
magnitude (8). Hormonal control of the biosynthesis and degradation of F26P2 facilitates 
regulation of glycolysis and gluconeogenesis through the coordinated modulation of fructose-
6-phosphate 1-kinase and FBPase activities (4,9). 
FBPase is a homotetramer [subunit Mr of 37,000 (10)] and exists in at least two 
distinct quaternary conformations called R and T (11,12). AMP induces the transition from 
the active R-state to the inactive (or less active) T-state. Substrates or products in 
combination with metal cations stabilize the R-state conformation. A proposed mechanism 
for allosteric regulation of catalysis involves three conformational states of loop 52-72 called 
engaged, disengaged, and disordered (13). AMP alone or with F26P%, stabilizes a disengaged 
loop (14,15), whereas metals with products stabilize an engaged loop (15,16). The enzyme is 
active if loop 52-72 can cycle between its engaged and disordered conformations. 
Fluorescence from a tryptophan reporter group at position 57 is consistent with the 
conformational states for loop 52-72, observed in crystal structures (17,18). Presumably, the 
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engaged, disengaged and disordered conformations of loop52-72 are possible in both the R-
and T-states of FBPase, but only the engaged and disordered conformera of the R-state, and 
the disengaged conformer of the T-state, have been reported in crystalline complexes 
(16,19,20). 
A central question remains concerning the allosteric regulation of FBPase: by what 
mechanism does AMP-cooperativity occur in the allosteric inhibition of FBPase? Lipscomb 
and colleagues (21) have described potential routes of AMP communication across two 
different subunit interfaces (CI to C4 and CI to C2; Fig. 1). In addition, interactions of the 
N-terminal segment could provide yet another pathway of communication between subunits 
CI and C2 (19). Mutations of residues throughout the enzyme, including both interfaces and 
loop 52-72, have eliminated AMP-cooperativity. In many instances, however, significant 
changes in kinetic parameters and/or mechanisms that accompany the loss of AMP-
cooperativity thwart definitive conclusions. 
Hetero-oligomers, or hybrids, of an otherwise homo-oligomeric protein can be used 
to great advantage in dissecting mechanisms of thermodynamic coupling between ligands. 
Hybrid constructs of aspartate carbamoyltransferase have revealed pathways of signal 
propagation and conformational changes due to the binding of allosteric effectors (22-25). 
Hybrid enzymes of lactate dehydrogenase from Bifidobacterium longum have demonstrated a 
concerted transition between the R- and T-states of that enzyme (26,27). 
On the basis of previous work, distinct homotetramers of FBPase, when combined 
under the appropriate conditions, undergo spontaneous subunit exchange to form-hybrid 
tetramers. Anion-exchange chromatography cleanly separates most of the hybrid constructs 
(28). More recently, Kantrowitz and colleagues (29) reported that AMP must bind to two 
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subunits of FBPase in order to cause significant inhibition. They were unable to investigate 
the origin of AMP-cooperativity, however, as their system was an unresolved mixture of 
three distinct 2:2 hybrid tetramers (29). Our motivation for developing an in vitro subunit 
exchange protocol lay in its potential to exercise control over the formation and separation of 
hybrid tetramers. As distinct 2:2 hybrids can be isolated by protocols presented here, specific 
pathways of cooperativity can be tested. The kinetic and equilibrium binding data presented 
here show that one molecule of AMP must bind to each half (top/bottom) of the FBPase 
tetramer in order to promote cooperative AMP-inhibition; however, AMP molecules bound 
to the same half of the tetramer can still elicit complete allosteric inhibition without 
cooperativity. Furthermore, the ligation of AMP molecules to any pair of subunits of the 
tetramer will promote an R- to T-transition. 
Materials and Methods 
Materials— FI6P2, F26P:, NADP+ and AMP were purchased from Sigma. Glucose-6-
phophate dehydrogenase and phosphoglucose isomerase came from Roche. Other chemicals 
were of reagent grade or the equivalent. QSW-HR HPLC resin was from Toso-Hass 
Bioseparations. The FBPase-deficient Escherichia coli strain DF 657 came from the Genetic 
Stock Center at Yale University. Plasmids used in the expression of wild-type and 
Tyr57—>Trp FBPases came from a previous investigation (17,18). Sigma Genosys provided 
all oligonucleotides used in directed mutations. 
Mutagenesis of Wild-Type FBPase— Mutations were accomplished by deletion of or specific 
base changes in double-stranded plasmids using the Quickchange™ site-Directed 
Mutagenesis kit (Stratagene). The following FBPases were developed in the context of work 
presented here: (1) Glu-tagged (the wild-type subunit with an extension of 9 glutamic acid 
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residues to its C-terminus), (//) Tyrll3-*Phe mutant, (z/ï) TyrIl3->Phe/LysU2->Met double 
mutant, (iv) AMP" (the Tyrll3->Phe/LysI12^Met/Thr31—>Val triple mutant), (v) 
Gly26—>Ile/Thr27->Asp double mutant, and (W) AMPTTrp57 (the 
Tyr1 l3->Phe/Lys' l2->Met/Thr3l->Val/ Tyr^7-»Trp quadruple mutant). The mutations and 
integrity of the resulting genes were confirmed by sequencing the promoter region and the 
entire open reading frame. The Iowa State University sequencing facility provided DNA 
sequences using the fluorescent dye-dideoxy terminator method. 
Expression and Purification of Wild-Type and Mutant Homotetramers—All of the FBPases 
were expressed in a strain of E. coli deficient in endogenous FBPase and then purified to 
homogeneity. Cell-free extracts of the wild-type and Glu-tagged FBPases were subjected to 
heat treatment (65° C for 5 minutes), followed by centrifugation. The supernatant solution 
was loaded onto a Cibracon Blue sepharose column, previously equilibrated with 20 mM 
Tris-HCl, pH 7.5. FBPases were eluted from that column with 1 mM AMP and 20 mM Tris-
HCl, pH 7.5. The eluent was loaded directly onto a DEAE sepharose column and eluted with 
a gradient of NaCl from 0-0.3 M. Constructs ii-vi above (all of which are impaired with 
respect to AMP binding) were purified as above, but using instead a NaCl gradient from 0-
0.7 M to elute proteins from the Cibracon Blue column. These AMP-impaired FBPases 
required an additional step of purification using phosphocellulose chromatography. A 
phosphocellulose column was equilibrated against 20 mM Tris-HCl, pH 7.5and the above 
enzymes were eluted with 5 mM FI6P2 and 20 mM Tris-HCl, pH 7.5. All proteins were 
dialyzed extensively against 20 mM Tris-HCl, but FBPases with impaired AMP binding 
(constructs ii-vi above) were dialyzed first against 1 mM MgCla, followed by 20 mM Tris-
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HC1. The latter procedure removed FI6P2 introduced during phosphocellulose 
chromatography. Protein purity and concentration was confirmed by SDS-polyacrylamide 
gel electrophoresis (30) and the Bradford assay (31), respectively. 
Formation and Purification of Hybrid Enzymes— Hybridization protocols developed here 
employed only pure FBPases. Appropriate enzymes were combined overnight at 4°C, after 
which the mixture was loaded onto a QSW-HR HPLC column, previously equilibrated with 
20 mM Tris-HCl, pH 7.5. Individual hybrids were eluted with 20 mM Tris-HCl, pH 7.5, and 
a gradient from 0-0.3 M in NaCl. The nomenclature of 2:2 hybrids used here is that of 
Comish-Bowden and Koshland (32). The letters p, q and r refer to 2:2 hybrids with like 
subunits at positions C1/C2, C1/C4, and C1/C3 of the tetramer, respectively (Fig. 2). 
Differences in electrostatic charge of various tetramers due to different numbers of 
polyglutamyl tags permitted the partial assignment of peaks in the elution profile to specific 
hybrids that formed from protocol A of Fig. 2. Retention times should increase with the 
number of Glu-tagged subunits in a tetramer. Indeed, the retention times of pure wild-type 
homotetramer and pure Glu-tagged homotetramer correspond to those of the first and last 
peaks eluted from hybrid mixtures. The second and penultimate peaks were assigned to 3:1 
hybrids (3-subunits wild-type to 1-subunit Glu-tagged) and to 1:3 hybrids (1-subunit wild-
type to 3-subunits Glu-tagged), respectively. The three possible 2:2 hybrids resolved into 
two peaks. Assignments of hybrid-type to these peaks entailed hybridization protocols B and 
C of Fig. 2. In the presence of FI6P2, subunit exchange occurs only at the level of C1/C2 
dimers (28). Hence, protocol B leads to hybrids 4:0,0:4 and 2:2p. The corresponding 
elution profile has but three peaks, the assignment of two of which (hybrids 4:0 and 0:4) is 
unambiguous. The central peak of the elution profile of protocol B, which must the 2:2p 
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hybrid, corresponds in retention time to one of two 2:2-hybrid peaks from the elution profile 
of protocol A. Using a similar process protocol C leads to a mixture of 2:2q and 2:2r 
hybrids. The corresponding elution profile again has three peaks, with the third peak being 
unambiguously due to the mixture of 2:2q/2:2r hybrids. The retention time of the 2:2q/2:2r 
hybrids from protocol C corresponds to the other 2:2-hybrid peak of protocol A. In order to 
arrest subunit exchange in purified hybrid enzymes, the hybrids were kept at room 
temperature (which slows subunit exchange). All kinetics and fluorescence experiments 
were performed within 3 hours of hybrid purification. After the assays had been performed, 
hybrid enzymes were checked with non-denaturing polyacrylamide gel electrophoresis to 
ensure the absence of subunit exchange. 
Circular Dichroism Spectroscopy— Circular dichroism spectra were recorded for wild-type 
and mutant FBPases at room temperature on a Jasco J710 CD spectrometer in a 1 cm cell, 
using a protein concentration of 0.35 mg/mL. Spectra were collected from 200-260 nm in 
increments of 1.3 nm. The spectra analyzed were an average of three independent scans. 
Each spectrum was blank corrected using the software package provided with the instrument. 
Kinetic Experiments—Assays for the determination of specific activity, and activity 
ratios at pH 7.5 and 9.5 employed the coupling enzymes, phosphoglucose isomerase and 
glucose-6-phosphate dehydrogenase (1). The reduction of NADP+ to NADPH was 
monitored by absorbance spectroscopy at 340 nm. All other assays used the same coupling 
enzymes, but monitored NADPH production by its fluorescence emission at 470 nm, using 
an excitation wavelength of 340 nm. Kinetic assays were performed at room temperature 
(22°C). Initial kinetic rates were analyzed using programs written either in the MINITAB 
language, using an a value of 2.0 (33) or by the ENZFITTER program (34). 
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Steady-State Fluorescence Measurements— Fluorescence data were collected using a SLM 
8100C Spectrofluorimeter from Spectronic Instruments. The single tryptophan at position 57 
was excited selectively using a wavelength of 295 nm. Fluorescence emission spectra were 
recorded in steps of 1 nm from 310-400 nm with a slit width of 2 nm for both excitation and 
emission. The spectra presented are the average of 3 scans. Enzyme concentrations ranged 
from 0.2-0.3 mg/mL. As a control, the highest concentration of AMP used here caused no 
change in fluorescence emission from a solution of tryptophan (100 pM) or from the 
AMPTTrp57 homotetramer. 
AMP titration data were analyzed by non-linear least squares fits, using the following 
equation: 
AF (AFml]C/F0)^^^' 
'
^0 Kd+L" 
(Eq. 2) 
where AF^,* is the change in fluorescence caused upon addition of ligand L, F0 is the 
fluorescence in the absence of ligand, K& is the dissociation constant, and n is the Hill 
coefficient. 
Results 
Expression and Purification of Wild-Type and Mutant Homotetramers—Expression and 
isolation procedures described above provided homotetramers of FBPase at least 95% pure 
by SDS-polyacryamide gel electrophoresis (data not shown). AMP-impaired FBPases 
(constructs ii-vi described above) did not elute from the Cibacron blue column, using AMP 
concentrations up to 20 mM. A gradient in NaCl successfully eluted these enzymes, but an 
additional purification step (phosphocellulose chromatography) was necessary in order to 
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achieve at least 95% purity. 
Formation and Purification of Hybrid Tetramers— Subunit exchange between Glu-tagged 
(9-residue polyglutamyl extension to the C-terminus) and AMP- homotetramers, and 
between Glu-tagged and AMPTTrp57 homotetramers, occurs at rates comparable to that of 
Glu-tagged and wild-type homotetramers. By the strategy presented in the Methods section, 
peaks with retention times of approximately 43 and 52 minutes (Fig. 2) correspond to a 
mixture of 2:2q and 2:2r hybrids and to a pure 2:2p hybrid, respectively. The kinetic 
properties of the 2:2p hybrid created by protocol A or B (Fig. 2) are quantitatively identical. 
Over several preparations, the 2:2q/2:2r hybrid mixtures from protocols A and C differ 
reproducibly, but not to a statistically significant extent. The 2:2q/2:2r hybrid mixture from 
protocol A has a lower Hill coefficient for AMP (1.4±0.l) and a higher IC50 (11.3±0.8) than 
that exhibited by the 2:2q/2:2r hybrid mixture from protocol C (Table I). As the relative 
amounts of Glu-tagged and AMP" subunits are different in protocols A and C, and as 
protocol C employs FI6P2, whereas protocol A does not, the relative amounts of 2:2q and 
2:2r need not be the same for each protocol. The purity of each hybrid was confirmed using 
native gel electrophoresis (Fig. 3) 
Secondary Structure Analysis— The CD spectra of all homotetramers and hybrids are 
identical from 200-260 nm (data not shown), indicating little or no effect on the secondary 
structure of FBPase due to mutations and hybridization protocols. 
Kinetics Experiments—Kinetic parameters of wild-type, Glu-tagged, AMP", and Tyr57—>Trp 
homotetramers, as well as specific hybrids from subunit exchange between Glu-tagged and 
AMP" homotetramers are in Table I. The Glu-tag does not perturb functional properties as 
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evidenced by the nearly identical kinetic parameters for the wild-type and Glu-tagged 
homotetramers. The AMP" homotetramer exhibits nearly a 12,000-fold decrease in AMP-
inhibition and some loss of AMP-cooperativity with no change in any other kinetic property. 
The mechanism of AMP-inhibition for the AMP" homotetramer is uncertain. AMP may bind 
to the active site and/or Na+ introduced along with the AMP may displace Mg2+ from the 
active site. Hence, the observed cooperativity (Hill coefficient of 1.4; Table I) for this low 
affinity interaction probably arises from a mechanism entirely different from that of the high-
affinity AMP-inhibition. Other homotetramers, not fully characterized kinetically, revealed 
IC50 values for AMP of 4,6, and 3 mM for Tyr1,3->Phe, Tyr1 l3->Phe/Lys' l2->Met, and 
Gly^-tlle/Thr^-tlle FBPases, respectively. The later double mutation confirms speculation 
regarding the loss of AMP recognition by chloroplast FBPases (35). The 
Gly^-frlle/Thr27—>Ile mutations create a chloroplast "AMP" pocket within the context of the 
porcine liver enzyme and a concomitant rise (3000-fold) of IC50 relative to that of the wild-
type enzyme. The AMP- homotetramer was used in subsequent subunit exchange 
experiments, because it has the highest IC50 for AMP, while preserving all other kinetic 
properties of the wild-type enzyme. 
Experiments in kinetics were performed immediately following the purification of 
hybrid enzymes. Hybrid tetramers were stable for several hours at 25°C (but not at 4°C). All 
the kinetic parameters of the hybrids were essentially identical to those of the wild-type 
enzyme, except those for AMP inhibition (Table I). 
Inhibition of Hybrid Tetramers by AMP— All enzymes with at least two functional AMP 
binding sites display complete inhibition at saturating concentrations of AMP (Fig. 4). The 
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ICso for the 2:2p hybrid is approximately 40 pM with a Hill coefficient of 1.0. Inhibition is 
complete upon saturation of the two high-affinity AMP binding sites. In contrast, AMP-
inhibition of the 2:2q/2:2r hybrid mixture is cooperative and 100% at saturation. The 
2:2q/2:2r hybrid mixture has an IC50 of 6.1 pM with a Hill coefficient for AMP of 1.5. The 
hybrid enzyme with 3 functional AMP binding sites and a single AMP-impaired binding site 
(1:3 hybrid, Fig. 2) responds to AMP much like the 2:2q/2:2r hybrid mixture with a Hill 
coefficient of 1.6 and an IC50 for AMP of 6.8 pM. The 3:1 hybrid, with only a single 
functioning AMP site, displays biphasic AMP inhibition, with 70% of the total activity 
remaining after the first phase of inhibition (Fig. 5). 
Steady-State Fluorescence— AMP-induced changes in the fluorescence of hybrid FBPases 
are due to conformational changes in loop 52-72 of subunits, which do not possess 
functional AMP binding sites. Hence, the reporter groups sense conformational change due 
to AMP-ligation of a neighboring subunit. This conformational change is most likely the 
transition from R- to T-state FBPase. 
Fluorescence spectra of Trp57 FBPase (Fig. 6) are consistent with three 
conformational states of loop 52-72, observed in previous work (17,18). All hybrids exhibit 
identical fluorescence spectra in the presence of products and divalent cations (R-state, loop 
engaged), and in the absence of all ligands (R-state, loop disordered). Hybrids 0:4, 1:3, 2:2p 
and 2:2q/2:2r are sensitive to AMP, and at saturating levels of AMP attain nearly equivalent 
fluorescence spectra. In contrast, the fluorescence spectrum of AMPTTrp57 hybrids 3:1 and 
4:0 are insensitive to AMP. Evidently, loops 52-72 of these FBPase hybrids cannot achieve 
the T-state, disengaged loop conformation. 
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Changes in fluorescence in response to the titration of AMP confirm the absence of 
cooperativity in 2:2p hybrid tetramer and the existence of cooperativity in AMP-Iigation of 
the 2:2q/2:2r and 1:3 hybrid tetramers (Table II). Dissociation constants determined by 
fluorescence spectroscopy mirror the variation in IC50 values. The K4 values for the 
2:2q/2:2r and 1:3 hybrids are substantially lower than that of the 2:2p hybrid tetramer. 
Discussion 
Kinetic parameters (&*», ratio of activities at pH 7.5 and 9.5, Km for F16P2, ATa for 
Mg2+, Hill coefficient for Mg2+, and K\ for F26P:) and kinetic mechanisms of inhibition are 
virtually identical for hybrid and wild-type enzymes (Table I). Henceforth the discussion 
will focus on the two phenomena that differ: AMP cooperativity and AMP inhibition. 
Cooperativity can be a property of the entire oligomer, in which case the Hill 
coefficient varies smoothly with the number of functional ligand binding sites in hybrid 
constructs. Such is the case for hybrids of lactate dehydrogenase from Bacillus longum (26). 
On the other hand, if the mechanism of cooperativity relies on the integrity of a specific 
subunit interface, then mutations at that interface should eliminate cooperativity, whereas 
mutations elsewhere should have no effect. Cooperativity in the binding of NAD to 
tetrameric glyceraldehyde 3-phosphate dehydrogenase, for instance, is sensitive to the O-P 
interface (46). 
Neither of these scenarios, however, applies to FBPase. The lack of cooperativity in 
AMP inhibition of the 2:2p hybrid indicates no participation by the C1-C2 interface in this 
phenomenon. On the other hand, the 0:4 hybrid (Glu-tagged homotetramer) and the 1:3 
hybrid (1 subunit AMP13 subunits Glu-tagged) have Hill coefficients for AMP of 2.0 and 
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1.6, respectively, suggesting some correlation between the number of functional binding sites 
and the Hill coefficient. If 2:2 hybrids can have cooperativity no greater than that of the 1:3 
hybrid, then the Hill coefficient of 1.5 for the 2:2q/2:2r hybrid mixture requires either one of 
the hybrids (2:2q or 2:2r) is dominant and cooperative or that both hybrids are cooperative. 
Of the two possibilities, mentioned above, the latter is most probable. To have the 
formation of say the 2:2q hybrid, but not the 2:2r hybrid, requires either a bias in the 
equilibrium distribution of hybrids or a bias in the kinetics of subunit exchange. Although 
the relative areas of peaks in the elution profile of Fig 2 A are not consistent with a binomial 
distribution, we see no evidence that would suggest a thermodynamic bias so large as to 
exclude the formation of any specific hybrid. Furthermore, we can envision a mechanism of 
subunit exchange that discriminates against the formation of both hybrids 2:2q and 2:2r, but 
no mechanism that leads to the formation of just one of these hybrids. The data here infer 
then, comparable levels of each hybrid in the 2:2q/2:2r mixture, and hence both the 2:2q and 
2:2r hybrids must have nearly equal AMP-cooperativity. 
Directed mutations that alter AMP cooperativity in a homotetramer of FBPase 
generally do not support a definitive conclusion regarding the mechanism of cooperativity 
(36-41). Mutations of Arg49 or Lys50 (residues located at the C1-C2 interface) eliminate 
AMP cooperativity (40,41), but they also change the kinetic mechanism of AMP inhibition 
from noncompetitive to uncompetitive with respect to FI6P2 and from competitive to 
noncompetitive with respect to Mg2+. One can infer little regarding cooperativity in a kinetic 
mechanism, if the mechanism itself is changed by the experiment. Indeed, the mutation of 
Lys50 to methionine has no effect on kinetic mechanisms, and little or no effect on kinetic 
parameters, including AMP cooperativity (40). Mutations of Arg49 and Lys50 that result in 
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significant functional perturbations are due most likely to their influence on the 
conformational dynamics of loop 52-72. Mutations of Asn64, Asp74 and Glu98, residues in or 
near loop 52-72, eliminate AMP cooperativity (43,44). The introduction of proline at 
position 50 dramatically alters the mechanism of AMP-inhibition and, on the basis of 
fluorescence spectroscopy, greatly changes the conformational dynamics of loop 52-72 (45). 
In contrast, the 2:2p hybrid preserves all of the kinetic properties of the wild-type enzyme, 
save AMP-cooperativity. 
There are, however, mutations that eliminate AMP-cooperativity with only modest 
effects on other kinetic parameters. Mutations of Lys42, Ile190, Gly191 and Glu'92 (residues at 
the C1-C4 interface) are such examples (38,39). The above mutants of FBPase exhibit 
biphasic inhibition by AMP: maximal inhibition of substantially less than 100% at low 
concentrations of AMP (<10 pM), followed by complete inhibition at concentrations of AMP 
>10 mM. Lu et al. (37) concluded such biphasic AMP-inhibition is a consequence of lost 
AMP-cooperativity. The 2:2p hybrid, however, has no AMP-cooperativity and no biphasic 
AMP-inhibition. An alternative model by Nelson et al. (13) accounts for biphasic AMP-
inhibition as a failure to stabilize the disengaged conformation of loop 52-72. Hence, 
catalysis in the presence of AMP arises from the T-state of FBPase, and the observed 
maximal inhibition at low concentrations of AMP is due to the transition from an active In­
state to a less active T-state. The later model accounts for biphasic AMP-inhibition, but says 
nothing regarding the mechanism of AMP-cooperativity. 
Of the several mutations that eliminate AMP-cooperativity in homotetramers of 
FBPase, the mutation of Arg22 to methionine perhaps makes the most compelling case for the 
participation of a specific subunit interface in the mechanism of AMP-cooperativity. Met22 
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FBPase exhibits no cooperativity in AMP-inhibition, yet retains all other wild-type kinetic 
mechanisms and parameters (36). Arg22 (of subunit Cl) hydrogen bonds with backbone 
carbonyl 27 (of subunit C4) in the T-state of wild-type FBPase. This intersubunit hydrogen 
bond is absent, however, in the R-state. The absence of AMP cooperativity in Met22 FBPase 
implicates the top/bottom (C1-C4/C2-C3) interface in the phenomenon. As the top/bottom 
interface extends the entire width of the FBPase tetramer (Fig 1), the coupling mechanism 
responsible for cooperativity can involve any pair of AMP molecules bound to opposite sides 
of the interface. The observation of cooperativity in the 2:2q/2:2r hybrid mixture and its 
absence in the 2:2p hybrid is fully consistent with a mutation that evidently severs 
communications between the top and bottom halves of the FBPase tetramer. > 
Although AMP-cooperativity may not be inseparably linked to allosteric inhibition, 
as noted above, AMP-affinity and -cooperativity are correlated phenomena. Cooperativity is 
highest and IC50 for AMP is lowest in the 0:4 hybrid (Glu-tagged homotetramer). As the 
number of AMP" subunits increases in the hybrid, the Hill coefficient declines and IC50 for 
AMP rises. The 1:3 hybrid and the 2:2q/2:2r hybrid mixture are the exceptions to this trend. 
In fact, the kinetic properties of the 1:3 hybrid and 2:2q/2:2r hybrid mixture are nearly 
identical, whereas the 2:2p hybrid has no cooperativity and an IC50 for AMP some 6-fold 
higher. Evidently, potent and cooperative AMP inhibition of FBPase requires at least one 
AMP molecule bound to each half (top/bottom) of the tetramer. This finding is in harmony 
with evidence for pairs of high and low affinity sites for AMP on wild-type FBPase (46). 
The fluorescence data infer a common R-state conformation for hybrids, and a global 
conformational change induced by saturating concentrations of AMP. The Trp57 reporter 
group behaves as if the 1:3 and 2:2 hybrids are undergoing the same R- to T-state transition 
154 
as observed in the wild-type enzyme. The 12-fold rise in ATd for AMP, exhibited by the 2:2p 
hybrid relative to theTrp57 homotetramer, reflects most likely the diversion of more AMP 
binding energy to promote the R- to T-state transition. Hence, one molecule of AMP ligated 
to each half (top/bottom) of the tetramer is more effective in driving the R- to T-state 
transition, than a pair of AMP molecules bound to the same half of the tetramer. A 3:1 
hybrid (3 subunits AMP~:1 subunit Glu-tagged) of FBPase is poorly inhibited by AMP (IC50 
of 340 nM) and, on the basis of fluorescence spectroscopy, cannot drive the R- to T-
transition. Data here from thermodynamics and kinetics then are in substantial agreement: 
potent and cooperative inhibition of FBPase occurs by the binding of one AMP molecule to 
each of the bottom and top halves of the tetramer, driving an R- to T-state transition. 
These findings indicate two possible pathways of allosteric inhibition: a cooperative 
pathway, triggered by the binding of a pair of AMP molecules to opposites sides of the 
top/bottom interface, and a non-cooperative pathway, triggered by the binding of a pair of 
AMP molecules to the same side of the top/bottom interface. Given the relative IC50 values 
for AMP-inhibition of the 2:2 hybrid tetramers, AMP prefers binding to opposite sides of the 
top/bottom interface. Formycin A 5'-monophosphate (FMP) and 2'(3')-0-
(trinitrophenyl)adenosine 5'-monophosphate, however, cause complete allosteric inhibition 
with no cooperativity (7,45). For reasons unknown, the later effectors may prefer binding to 
the same side of the top/bottom interface of the wild-type tetramer, and thus the absence of 
cooperativity in allosteric inhibition. Crystal structures of human FBPase, fully ligated with 
AMP and with formycin A 5'-monophosphate, however, reveal no discernable differences 
(47). Hence, differences in AMP and FMP complexes of FBPase must lie in partially ligated 
states of the enzyme, a conclusion at least consistent with the observed functional properties 
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of the 2:2 hybrid tetramers. 
Ackers et al. (48) have proposed a "symmetry rule" governing the transition of 
hemoglobin from its T- to R-states. The hemoglobin tetramer is composed of two ap dimers. 
The association of at least one ligand to each of the ap dimers of the hemoglobin tetramer 
favors a T- to R-state transition. In contrast, the R- to T-state transition for FBPase occurs 
whether ligands bind to opposite halves or to the same half of the tetramer. 
How then is it possible for AMP to promote an R- to T-state transition in FBPase with 
and without cooperativity? A possible explanation appears in Fig. 7, where AGb is the free 
energy change in the ligation of AMP to an "isolated subunit" of FBPase, AGtcrt is the free 
energy penalty in overcoming tertiary conformational restraints due to the assembly of the 
"isolated subunit" into an R-state relative to a T-state tetramer, and AGRT is the free energy 
penalty in overcoming quaternary conformational restraints in the R- to T-state transition. As 
unligated and singly-ligated tetramers favor the R-state, AGRT > AGicrt. As doubly-ligated 
tetramers are in the T-state, however, 2AGtett > AGRT- The last two inequalities can be 
combined: 2AGRT > 2AG^ > AGRT. Cooperative binding of AMP to the 2:2q hybrid 
tetramer, requires only that AGb+AGtert > AGb+AGRT-AGtem or equivalently, 2AGten > AGrt , 
which clearly agrees with the relative free energies of unligated, singly-ligated, and doubly-
ligated FBPases. 
In order to account for noncooperative binding of AMP, we assume a thermodynamic 
penalty (AGP in Fig. 7) in the binding of two AMP molecules to the same half of the tetramer. 
Such a thermodynamic penalty is consistent with the weaker binding affinity of the third and 
fourth molecules of AMP to the wild-type tetramer (46). Noncooperative binding of AMP 
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then requires AGb+AGtert = AGb+AGRT-AG,ert+AGp, or equivalently, 2AGtert = AGRT+AGP. 
This latter equality and the former combined inequality (2AGRT > 2AG^ > AGRT) together 
require only that AGRT > AGP > 0, which is a plausible condition. Hence, the same allosteric 
effector of FBPase can promote an R- to T-state transition by way of either cooperative or 
noncooperative binding pathways. 
Abbreviations 
FBPase, fructose-1,6-bisphosphatase; FI6P2, fructose 1,6-bisphosphate; F6P, fructose 6-
phosphate; F26Pz, fructose 2,6-bisphospate; Pi, orthophosphate; AMP™, triple mutation 
TyrII3->Phe/Lys"2->Met/Thr"->Val; Glu-tagged, C-terminal extension of 9 glutamic acid 
residues. 
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Table 1 
Kinetic parameters for wild-type, mutant, and hybrid FBPases. 
Names of the FBPases are defined In the methods section and Fig. 2. 
FBPase Activity- kca." Km-F16P2c Ka-Mg2+ Hill Mg2+d Ki-F26P2c IC50-AMP1 Hill AMP 
ratio8 (sec"') (HM) (mM2) (MM) (MM) (HM) 
Wild-type 3.3 22+1 1.8±0.1 0.67±0.04 1.910.1 0.1210.01 1.6110.05 2.210.1 
Tip57 3.3 24±1 3.4±0.1 0.53±0.06 1.9±0.1 0.84±0.05 8.5±0.4 2.110.1 
Glu-tagged 3.5 23±1 2.2±0.1 0.65±0.05 2.110.1 0.1110.01 1.410.1 2.010.1 
1:3 3.5 22±2 2.2±0.2 0.35±0.03 2.2±0.1 0.16±0.02 6.1±0.3 1.6±0.1 
2:2q/2:2r 3.3 21±1 1.8±0.1 0.59±0.04 2.0±0.1 0.15±0.01 6.810.5 1.5ml 
2:2p 3.4 23±2 1.7±0.1 0.41±0.05 2.0±0.1 0.183±0.02 43±2 0.99±0.05 
3:1 3.2 22±1 1.8±0.2 0.39±0.02 2.2±0.1 0.20±0.01 340±10f 1.00±0.04 
AMP" 3.2 21 ± 1 2.710.1 0.4610.03 2.11.0.1 0.1510.01 117001600 1.410.1 
"Ratio of specific activities at pH 7.5 and 9.5. 
''Determined at saturating substrate concentrations. 
'Determined at a Mg2* concentration of 5 mM. 
'Determined at a FI6P2 concentration of 20 pM. 
'Determined at a Mg2+ concentration equal to the tfa-Mg2+ of each enzyme and a F16P2 concentration of 20 pM. 
Value calculated using normalized data shown in the inset of Fig. 5. 
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Table 2 
Dissociation constants and Hill coefficients for AMPTTrp57 FBPase hybrids. 
Corresponding data provided for Trp57 FBPase from reference (17). 
FBPase Kd Hill coefficient 
Trp57 17±1 2.1±0.1 
1:3 21.2±0.8 1.60±0.09 
2:2q/2:2r 42+3 1.510.1 
2:2p 210±I0 1.010.1 
3:1 400±70 0.8±0.1 
Fig. 1. Cartoon of FBPase showing subunit and interface nomenclature. Active sites 
and AMP-binding sites are labeled F6P and AMP, respectively. Dashed circles 
represent ligand binding sites on the face hidden from view. 
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Left/Right or C1-C2/C3-C4 
Interface 
F6P 
Top/Bottom or 
C1-C4/C2-C3 
Interface 
Fig. 2. Protocols for hybridization and the assignment of hybrid types to elution 
profiles. (A) General method provides all possible hybrid tetramers between AMP" 
and Glu-tagged homotetramers. (B) Special method for generating the 2:2p hybrid 
tetramer without 2:2q and 2:2r hybrid tetramers. (C) Special method for generating 
2:2q and 2:2r hybrid tetramers without the 2:2p hybrid tetramer. Shaded polygons 
represent subunits with non-functional AMP sites (AMP-) and open polygons with 
dotted extensions represent Glu-tagged subunits. Corresponding elution profiles and 
retention times are immediately below each protocol. Peaks marked with arrows 
represent inactive protein (FBPase activity in the elution profile for A is given by the 
dotted line and solid diamonds ). These peaks can be significant (as shown) or be 
absent from the elution profile, and are presumably unfolded and/or aggregated 
subunits of FBPase. 
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Fig. 3. Non-denaturing poiyacrylamide electrophoresis gel of purified hybrids. The 
name of the hybrid is above the lane. Tetramer hybrids 2:2q/2:2r and 2:2p each have 
two Glu-tags, but have different retention times in HPLC separations as demonstrated 
in Fig. 2. 
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mix 4:0 3:1 2:2q+r 2:2p 1:3 0:4 mix 
Fig. 4. Response of potently and completely inhibited FBPases to AMP. Curves 
represent wild-type (•), 1:3 (•), 2:2q/2:2r (A), and 2:2p (•) FBPases. The 
inhibition assays were performed in 20 pM FI6P2 and 0.5 mM Mg2+. 
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Fig. 5. Response of weakly inhibited FBPases to AMP. Curves represent 3:1 (•) and 
AMP" (•) FBPases. The inhibition assays were performed in 20 jiM FI6P2 and 0.5 
raM Mg2+. Inset The curve for the 3:1 tetramer hybrid less the calculated AMP-
inhibition based on the curve for the AMP- homotetramer. The "corrected" curve 
reveals the specific effect due to the high-affinity association of AMP with the single 
functional subunit of the 3 :1 hybrid tetramer. 
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Fig. 6. Fluorescence spectra of representative tetramer hybrids formed from 
AMP7Trp57 and Glu-tagged homotetramers. Bold lines represent conditions (5 
mM KPj, 5 mM F6P, and 50 pM ZnCla) under which the wild-type enzyme is in its 
R-state, loop-engaged conformation. Thin lines represent the apo enzyme (no ligands 
or metals present). Dashed lines represent conditions (5 mM KPj, 5 mM F6P, 50 pM 
ZnCh, and 1 mM AMP) under which the wild-type enzyme is in its T-state, loop 
disengaged conformation. Panel A is the 2:2p hybrid tetramer, B is the 2:2q+r hybrid 
tetramers, and C is the 3:1 hybrid tetramer. 
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Fig. 7. Thermodynamics of cooperative {left) and noncooperative {right) inhibition of 
2:2 hybrid tetramers of FBPase by AMP. Free energy terms AGb, AGtcrl, AGRT, 
and AGP are defined in the text. AMP cannot bind to subunits with crosses. R-state 
subunits are rounded, whereas T-state subunits have corners. Predominant forms of 
the tetramer in solution at equilibrium are represented with bold outlines. 
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CHAPTER 7. GENERAL CONCLUSIONS 
Summary 
The work described in this thesis represents a significant advancement in our 
knowledge of the mechanism of allosteric regulation of fructose-1,6-bisphosphatase. 
Chapters two and three test the current model for allosteric regulation, proposed shortly 
before the initiation of my research (1,2). In chapter two, a tryptophan reporter group was 
placed within loop 52-72 in order to observe the different conformations of the loop in 
solution (3). These studies indicate that all three states of the loop found in crystal structures 
occur in solution and clearly demonstrate the usefulness of the Trp57 reporter group as a 
probe of the conformation of loop 52-72. The tryptophan probe has been utilized in the 
hybrid enzyme system to determine the allosteric affects of AMP binding in a single subunit 
on the conformation of the loop in neighboring subunits. Additionally, the data indicate that 
the binding of F26Pa to the active site produces a similar conformational change in loop 52-
72 as the binding of AMP. 
In chapter three, the mobility of the loop 52-72 was restricted by replacement of the 
loop-hinge residues, Lys50 and Ala51, with proline (4). These experiments effectively 
demonstrate that the flexibility of the loop is integral to the mechanism of allosteric 
regulation by AMP. These data also support the hypothesis that F26P%/AMP synergism 
occurs through the mutual stabilization of the disengaged state of loop 52-72. 
Chapter four defines another flexible element that is involved in the allosteric 
regulation of catalysis, the N-terminal region (5). Deletion of the first ten residues, or 
specific point mutations in this region of the polypeptide chain drastically altered both 
catalytic activity and the mechanism of AMP inhibition. This work stresses the importance 
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of all three states of loop 52-72, the disordered, disengaged, and engaged. We proposed that 
the N-terminal region of the enzyme is required for stabilization of the disengaged state of 
the loop. In absence of the N-terminal region, the disordered and engaged states of the loop 
predominate in the T-state, producing an active T-state enzyme. In fact, when the I10D 
mutant is co-crystallized with AMP, F6P, Pi, and ZnCfe the loop 52-72 is engaged and in the 
global T-state conformation (Iancu, unpublished results). The direct observation of an 
engaged T-state loop is fully consistent with our thermodynamic loop model proposed in 
chapter four. 
In the final two chapters of this dissertation, subunit interactions are investigated. In 
chapter five, it is demonstrated by the observation of spontaneous subunit exchange that the 
FBPase tetramer can dissociate into dimers and monomers, a phenomenon never previously 
observed in FBPase (6). It was also demonstrated that active site ligands only allow subunit 
dissociation into dimers, and AMP eliminates dissociation completely, which suggests an 
ordered mechanism of subunit dissociation. In chapter six, subunit exchange is exploited in 
order to create hybrid enzymes between a mutant FBPase that is unable to bind AMP and 
wild-type subunits with an altered charge (7). This work demonstrated that in wild-type 
FBPase, the pathway of AMP communication occurs through the top-bottom dimer interface 
and indicates that there are two potential pathways for complete allosteric inhibition. 
Additionally, the hybrid enzyme with 3 AMP-disrupted subunits and 1 wild-type subunit 
demonstrated that the binding of a single AMP molecule cannot fully inhibit the enzyme, 
whereas binding of two AMP molecules in any arrangement results in complete inhibition. 
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